US 9,017,326 B2Grant

Impedance monitoring apparatus, system, and method for ultrasonic surgical instruments

Issue Date:2015-04-28

•24 Claims

•16 Drawing Sheets

Abstract

In one general aspect, various embodiments are directed to a surgical instrument that can supply mechanical energy and electrical energy to an end effector of the surgical instrument. The surgical instrument comprises an ultrasonic generator module coupled to an ultrasonic drive system, which comprises an ultrasonic transducer coupled to a waveguide and an end effector coupled to the waveguide. The ultrasonic drive system is configured to resonate mechanically at a resonant frequency to generate a first ultrasonic drive signal. An electronic circuit is coupled to the ultrasonic generator module to monitor an electrical characteristic of the ultrasonic drive system. A processor is coupled to the electronic circuit to control the ultrasonic drive signal in response to the monitored electrical characteristic of the ultrasonic drive system.

Metadata

Assignee

Ethicon Endo-Surgery, Inc.

Inventors

Brian DiNardo
David C. Yates
Jeffrey D. Messerly
Eitan T. Wiener
David A. Witt
James R. Giordano
Jeffrey L. Aldridge

Application Information

Application Number:US 12/503,766

Filing Date:2009-07-15

Priority Date:2009-07-15

Art Unit:3739

Classifications

IPC:

A61B17/285A61B17/3209A61B17/295A61B18/08A61B18/14A61B17/32A61B18/12A61B17/00A61B18/00

Patent Drawings (16 sheets)

Description

Background

[0001] The present disclosure generally relates to ultrasonic surgical systems and, more particularly, to ultrasonic systems that allow surgeons to perform cutting and coagulation.

[0002] Ultrasonic surgical instruments are finding increasingly widespread applications in surgical procedures by virtue of the unique performance characteristics of such instruments. Depending upon specific instrument configurations and operational parameters, ultrasonic surgical instruments can provide substantially simultaneous cutting of tissue and homeostasis by coagulation, desirably minimizing patient trauma. The cutting action is typically realized by an-end effector, or blade tip, at the distal end of the instrument, which transmits ultrasonic energy to tissue brought into contact with the end effector. Ultrasonic instruments of this nature can be configured for open surgical use, laparoscopic, or endoscopic surgical procedures including robotic-assisted procedures.

[0003] Some surgical instruments utilize ultrasonic energy for both precise cutting and controlled coagulation. Ultrasonic energy cuts and coagulates by using lower temperatures than those used by electrosurgery. Vibrating at high frequencies (e.g., 55,500 times per second), the ultrasonic blade denatures protein in the tissue to form a sticky coagulum. Pressure exerted on tissue with the blade surface collapses blood vessels and allows the coagulum to form a hemostatic seal. The precision of cutting and coagulation is controlled by the surgeon's technique and adjusting the power level, blade edge, tissue traction, and blade pressure.

[0004] A primary challenge of ultrasonic technology for medical devices, however, continues to be sealing of blood vessels. Work done by the applicant and others has shown that optimum vessel sealing occurs when the inner muscle layer of a vessel is separated and moved away from the adventitia layer prior to the application of standard ultrasonic energy. Current efforts to achieve this separation have involved increasing the clamp force applied to the vessel.

[0005] Furthermore, the user does not always have visual feedback of the tissue being cut. Accordingly, it would be desirable to provide some form of feedback to indicate to the user that the cut is complete when visual feedback is unavailable. Moreover, without some form of feedback indicator to indicate that the cut is complete, the user may continue to activate the harmonic instrument even though the cut is complete, which cause possible damage to the harmonic instrument and surrounding tissue by the heat that is generated exponentially when activating a harmonic instrument with nothing between the jaws.

[0006] It would be desirable to provide an ultrasonic surgical instrument that overcomes some of the deficiencies of current instruments. The ultrasonic surgical instrument described herein overcomes those deficiencies.

Summary

[0007] In one general aspect, various embodiments are directed to an ultrasonic surgical instrument that comprises a transducer configured to produce vibrations along a longitudinal axis at a predetermined frequency. In various embodiments, an ultrasonic blade extends along the longitudinal axis and is coupled to the transducer. In various embodiments, the ultrasonic blade includes a body having a proximal end and a distal end, wherein the distal end is movable relative to the longitudinal axis by the vibrations produced by the transducer.

[0008] In one general aspect, various embodiments are directed to a surgical instrument that can supply mechanical energy and electrical energy to an end effector of the surgical instrument. The surgical instrument comprises an ultrasonic generator module coupled to an ultrasonic drive system. The ultrasonic drive system comprises an ultrasonic transducer coupled to a waveguide and an end effector coupled to the waveguide. The ultrasonic drive system is configured to resonate mechanically at a resonant frequency. The ultrasonic generator module is to generate a first ultrasonic drive signal. An electronic circuit is coupled to the ultrasonic generator module to monitor an electrical characteristic of the ultrasonic drive system. A processor is coupled to the electronic circuit to control the ultrasonic drive signal in response to the monitored electrical characteristic of the ultrasonic drive system.

Figures

[0009] The features of various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with further objects and advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows.

[0010] FIG. 1 illustrates a surgical instrument comprising an ultrasonic surgical instrument system and an electrosurgery surgical instrument system.

[0011] FIG. 2 illustrates a portion of a handpiece assembly of the surgical instrument of FIG. 1 with a portion of the handpiece housing removed and an acoustic assembly operably engaged with a waveguide of the surgical instrument.

[0012] FIG. 3 illustrates the handpiece assembly of FIG. 2 with the acoustic assembly removed to illustrate positive and negative electrode contacts configured to supply the acoustic assembly with power.

[0013] FIG. 4 is a detail view of a portion of the acoustic assembly of FIG. 2.

[0014] FIG. 5 is a detail view of the end effector of the ultrasonic surgical instrument of FIG. 1.

[0015] FIG. 6 is a perspective view of an embodiment of a sheath assembly comprising an inner sheath and an outer sheath which can define a first passageway for a waveguide of an ultrasonic instrument and a second passageway for a return conductor.

[0016] FIG. 7 is a perspective view of an embodiment of a sheath configured to surround at least a portion of a waveguide of an ultrasonic surgical instrument, wherein a conductor can be embedded in at least a portion of a sheath.

[0017] FIG. 8 is a perspective view of an embodiment of a clamp arm assembly configured to hold tissue against a waveguide of an ultrasonic surgical instrument.

[0018] FIG. 9 is a perspective view of another embodiment of a clamp arm assembly having downwardly-extending walls which extend below a tissue-contacting surface.

[0019] FIG. 10 is a cross-sectional end view of the clamp arm assembly of FIG. 9 positioned in a closed position relative to a waveguide of an ultrasonic surgical instrument.

[0020] FIG. 11 is a perspective view of a tissue-contacting pad of a clamp arm assembly, wherein the pad includes first and second electrodes embedded therein and positioned relative to a waveguide of an ultrasonic surgical instrument.

[0021] FIG. 12 is a perspective view of another embodiment of a tissue-contacting pad of a clamp arm assembly, wherein the pad includes first and second electrodes mounted thereto and positioned relative to a waveguide of an ultrasonic surgical instrument.

[0022] FIG. 13 is a perspective view of another embodiment of a tissue-contacting pad of a clamp arm assembly, wherein the pad includes first and second point electrodes embedded therein.

[0023] FIG. 14 is a perspective view of an embodiment of a sheath configured to surround at least a portion of a waveguide of an ultrasonic surgical instrument, wherein first and second conductors can be embedded in at least a portion of a sheath.

[0024] FIG. 15 is a perspective view of an embodiment of a sheath assembly comprising an inner sheath and an outer sheath, wherein the inner sheath and the outer sheath may comprise first and second conductors.

[0025] FIG. 16 is an end view of a clamp arm assembly holding tissue against a waveguide.

[0026] FIG. 17 is an end view of an alternative embodiment of a clamp arm assembly holding tissue against a waveguide.

[0027] FIG. 18 illustrates one embodiment of a drive system of an ultrasonic generator module, which creates the ultrasonic electrical signal for driving an ultrasonic transducer.

[0028] FIG. 19 illustrates one embodiment of a drive system of a generator comprising a tissue impedance module.

[0029] FIG. 20 is a schematic diagram of a tissue impedance module coupled to a blade and a clamp arm assembly with tissue located therebetween.

Description

[0030] Before explaining various embodiments of ultrasonic surgical instruments in detail, it should be noted that the illustrative embodiments are not limited in application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative embodiments may be implemented or incorporated in other embodiments, variations and modifications, and may be practiced or carried out in various ways. Further, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments for the convenience of the reader and are not for the purpose of limitation thereof.

[0031] Further, it is understood that any one or more of the following-described embodiments, expressions of embodiments, examples, can be combined with any one or more of the other following-described embodiments, expressions of embodiments, and examples.

[0032] Various embodiments are directed to improved ultrasonic surgical instruments configured for effecting tissue dissecting, cutting, and/or coagulation during surgical procedures. In one embodiment, an ultrasonic surgical instrument apparatus is configured for use in open surgical procedures, but has applications in other types of surgery, such as laparoscopic, endoscopic, and robotic-assisted procedures. Versatile use is facilitated by selective use of ultrasonic energy.

[0033] It will be appreciated that the terms “proximal” and “distal” are used herein with reference to a clinician gripping a handpiece assembly. Thus, an end effector is distal with respect to the more proximal handpiece assembly. It will be further appreciated that, for convenience and clarity, spatial terms such as “top” and “bottom” also are used herein with respect to the clinician gripping the handpiece assembly. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and absolute.

[0034] The various embodiments will be described in combination with an ultrasonic instrument as described herein. Such description is provided by way of example, and not limitation, and is not intended to limit the scope and applications thereof. For example, any one of the described embodiments is useful in combination with a multitude of ultrasonic instruments including those described in, for example, U.S. Pat. Nos. 5,322,055; 5,449,370; 5,630,420; 5,935,144; 5,938,633; 5,944,737; 5,954,736; 6,278,218; 6,283,981; 6,309,400; 6,325,811; and 6,436,115, wherein the disclosure of each of the patents is herein incorporated by reference. Also incorporated by reference in its entirety is commonly-owned, co-pending U.S. patent application Ser. No. 11/726,625, entitled ULTRASONIC SURGICAL INSTRUMENTS, filed on Mar. 22, 2007. The disclosure of each of the following commonly-owned and contemporaneously-filed U.S. Patent Applications is incorporated herein by reference in its entirety:

- [0035] (1) U.S. patent application Ser. No. 12/503,769, entitled “ULTRASONIC SURGICAL INSTRUMENTS,” now U.S. Pat. App. Pub. No. 2011/0015631;
- [0036] (2) U.S. patent application Ser. No. 12/503,770, entitled “ULTRASONIC SURGICAL INSTRUMENTS,” now U.S. Pat. App. Pub. No. 2011/0015660; and
- [0037] (3) U.S. patent application Ser. No. 12/503,775, entitled “ULTRASONIC DEVICE FOR CUTTING AND COAGULATING WITH STEPPED OUTPUT,” now U.S. Pat. No. 8,058,771.

[0038] As will become apparent from the following description, it is contemplated that embodiments of the surgical instrument described herein may be used in association with an oscillator module of a surgical system, whereby ultrasonic energy from the oscillator module provides the desired ultrasonic actuation for the present surgical instrument. It is also contemplated that embodiments of the surgical instrument described herein may be used in association with a signal generator module of a surgical system, whereby electrical energy in the form of radio frequencies (RF), for example, is used to provide feedback to the user regarding the surgical instrument. The ultrasonic oscillator and/or the signal generator modules may be non-detachably integrated with the surgical instrument or may be provided as separate components, which can be electrically attachable to the surgical instrument.

[0039] One embodiment of the present surgical apparatus is particularly configured for disposable use by virtue of its straightforward construction. However, it is also contemplated that other embodiments of the present surgical instrument can be configured for non-disposable or multiple uses. Detachable connection of the present surgical instrument with an associated oscillator and signal generator unit is presently disclosed for single-patient use for illustrative purposes only. However, non-detachable integrated connection of the present surgical instrument with an associated oscillator and/or signal generator unit is also contemplated. Accordingly, various embodiments of the presently described surgical instruments may be configured for single use and/or multiple uses and with either detachable and/or non-detachable integral oscillator and/or signal generator modules, without limitation. All combinations of such configurations are contemplated to be within the scope of the present disclosure.

[0040] FIG. 1 illustrates one embodiment of a surgical system 100. The surgical system 100 includes a generator 112 and an ultrasonic surgical instrument 110. The generator 112 is connected to an ultrasonic transducer 114 portion of the ultrasonic surgical instrument 110 via a suitable transmission medium such as a cable 142. In one embodiment, the generator 112 is coupled to an ultrasonic generator module 180 and a signal generator module 102. In various embodiments, the ultrasonic generator module 180 and/or the signal generator module 102 each may be formed integrally with the generator 112 or may be provided as a separate circuit modules electrically coupled to the generator 112 (shown in phantom to illustrate this option). In one embodiment, the signal generator module 102 may be formed integrally with the ultrasonic generator module 180. Although in the presently disclosed embodiment, the generator 112 is shown separate from the surgical instrument 110, in one embodiment, the generator 112 may be formed integrally with the surgical instrument 110 to form a unitary surgical system 100. The generator 112 comprises an input device 406 located on a front panel of the generator 112 console. The input device 406 may comprise any suitable device that generates signals suitable for programming the operation of the generator 112 as subsequently described with reference to FIG. 18. Still with reference to FIG. 1, the cable 142 may comprise multiple electrical conductors 139, 141 for the application of electrical energy to positive (+) and negative (-) electrodes of the ultrasonic transducer 114. It will be noted that, in some applications, the ultrasonic transducer 114 may be referred to as a “handle assembly” because the surgical instrument 110 of the surgical system 100 may be configured such that a surgeon may grasp and manipulate the ultrasonic transducer 114 during various procedures and operations.

[0041] In one embodiment, the generator 112 may be implemented as an electro surgery unit (ESU) capable of supplying power sufficient to perform bipolar electrosurgery using radio frequency (RF) energy. In one embodiment, the ESU can be a bipolar ERBE ICC 350 sold by ERBE USA, Inc. of Marietta, Ga. In bipolar electrosurgery applications, as previously discussed, a surgical instrument having an active electrode and a return electrode can be utilized, wherein the active electrode and the return electrode can be positioned against, or adjacent to, the tissue to be treated such that current can flow from the active electrode to the return electrode through the tissue. Accordingly, the generator 112 may be configured for therapeutic purposes by applying electrical energy to the tissue T sufficient for treating the tissue (e.g., cauterization).

[0042] In one embodiment, the signal generator module 102 may be configured to deliver a subtherapeutic RF signal to implement a tissue impedance measurement module. In one embodiment, the signal generator module 102 comprises a bipolar radio frequency generator as described in more detail below. In one embodiment, signal generator module 102 may be configured to monitor the electrical impedance Z_tof tissue T (FIG. 5) and to control the characteristics of time and power level based on the tissue impedance Z_t. The tissue impedance Z_tmay be determined by applying the subtherapeutic RF signal to the tissue T and measuring the current through the tissue T (FIGS. 5, 10, 16, 17) by way of a return electrode provided on a clamp member 151, as discussed in more detail below. Accordingly, the signal generator module 102 may be configured for subtherapeutic purposes for measuring the impedance or other electrical characteristics of the tissue T. Techniques and circuit configurations for measuring the impedance or other electrical characteristics of the tissue T are discussed in more detail below with reference to FIGS. 18-20 below.

[0043] A suitable ultrasonic generator module 180 may be configured to functionally operate in a manner similar to the GEN 300 sold by Ethicon Endo-Surgery, Inc. of Cincinnati, Ohio as is disclosed in one or more of the following U.S. patents, all of which are incorporated by reference herein: U.S. Pat. No. 6,480,796 (Method for Improving the Start Up of an Ultrasonic System Under Zero Load Conditions); U.S. Pat. No. 6,537,291 (Method for Detecting a Loose Blade in a Handle Connected to an Ultrasonic Surgical System); U.S. Pat. No. 6,626,926 (Method for Driving an Ultrasonic System to Improve Acquisition of Blade Resonance Frequency at Startup); U.S. Pat. No. 6,633,234 (Method for Detecting Blade Breakage Using Rate and/or Impedance Information); U.S. Pat. No. 6,662,127 (Method for Detecting Presence of a Blade in an Ultrasonic System); U.S. Pat. No. 6,678,621 (Output Displacement Control Using Phase Margin in an Ultrasonic Surgical Handle); U.S. Pat. No. 6,679,899 (Method for Detecting Transverse Vibrations in an Ultrasonic Handle); U.S. Pat. No. 6,908,472 (Apparatus and Method for Altering Generator Functions in an Ultrasonic Surgical System); U.S. Pat. No. 6,977,495 (Detection Circuitry for Surgical Handpiece System); U.S. Pat. No. 7,077,853 (Method for Calculating Transducer Capacitance to Determine Transducer Temperature); U.S. Pat. No. 7,179,271 (Method for Driving an Ultrasonic System to Improve Acquisition of Blade Resonance Frequency at Startup); and U.S. Pat. No. 7,273,483 (Apparatus and Method for Alerting Generator Function in an Ultrasonic Surgical System).

[0044] In accordance with the described embodiments, the ultrasonic generator module 180 produces electrical signals of a particular voltage, current, and frequency, e.g. 55,500 cycles per second (Hz). The generator is 112 connected by the cable 142 to the ultrasonic generator module 180 in the handpiece assembly 160, which contains piezoceramic elements forming the ultrasonic transducer 114. In response to a switch 143 on the handpiece assembly 160 or a foot switch 144 connected to the generator 112 by another cable 105 the generator signal is applied to the transducer 114, which causes a longitudinal vibration of its elements. A structure connects the transducer 114 to a surgical blade 146, which is thus vibrated at ultrasonic frequencies when the generator signal is applied to the transducer 114. The structure is designed to resonate at the selected frequency, thus amplifying the motion initiated by the transducer 114. In one embodiment, the generator 112 is configured to produce a particular voltage, current, and/or frequency output signal that can be stepped with high resolution, accuracy, and repeatability.

[0045] Referring now to FIGS. 1-4, the handpiece assembly 160 of the surgical instrument system 110 may include a handpiece housing 116 that operably supports the end effector 150. The handpiece housing 116 rotatably supports an acoustic assembly 124 therein. The acoustic assembly 124 includes the ultrasonic transducer 114 that generally includes a transduction portion 118, a first resonator or end-bell 120, a second resonator or fore-bell 122, and ancillary components as shown in FIG. 2. In various embodiments, the ultrasonic energy produced by the transducer 114 can be transmitted through the acoustic assembly 124 to the end effector 150 via the ultrasonic transmission waveguide 147 as shown in FIGS. 1 and 3. In order for the acoustic assembly 124 to deliver energy to the waveguide 147, and ultimately to the end effector 150, the components of the acoustic assembly 124 are acoustically coupled to the blade 146. For example, the distal end of the ultrasonic transducer 114 may be acoustically coupled to the proximal end 170 of the waveguide 146 by a coupling assembly that enables the acoustic assembly 124 to freely rotate relative to the waveguide 147 while transmitting ultrasonic energy thereto.

[0046] As shown in FIG. 3, the proximal end 170 of the waveguide 146 may be provided with an aperture 172 therein that is sized to receive a stem (not shown) that protrudes distally from the fore-bell 122. In various embodiments, piezoelectric elements 132, for example, can be compressed between the end-bell 120 and the fore-bell 122 to form a stack of piezoelectric elements when the end-bell 120 and the fore-bell 122 are assembled together as illustrated in FIGS. 2-4. The piezoelectric elements 132 may be fabricated from any suitable material, such as, for example, lead zirconate-titanate, lead meta-niobate, lead titanate, and/or any suitable piezoelectric crystal material, for example. As shown in FIGS. 2 and 4, the transducer 114 may comprise electrodes, such as at least one positive electrode 134 and at least one negative electrode 136, for example, which can be configured to create a voltage potential across the one or more piezoelectric elements 132. As shown in FIG. 2, the positive electrode 134 and the negative electrode 136, and the piezoelectric elements 132 can each be configured with a bore (not shown) that cooperates to form a passageway that can receive a threaded portion of the end-bell 120. In one embodiment, the positive electrode 134 is provided in the form of an annular ring that has a first circumference “PC” and the negative electrode 136 is also provided in the form of an annular ring that has a second circumference “NC.” As shown in FIG. 2, in various embodiments, the stack of piezoelectric elements 132 may have an outer circumference “OC” that is less than the first and second circumferences “PC” and “NC.”

[0047] In various embodiments, the handpiece housing 116 may support the ultrasonic generator module 180 and/or the signal generator module 102. In one embodiment, the ultrasonic generator module 180 may be electrically coupled to an electrical contact assembly 190 that may comprise a positive slip ring contact 191 that is mounted within handpiece housing 116 for rotatable contact with the positive electrode 134. The positive slip ring contact 191 is electrically coupled to the ultrasonic generator module 180 by a positive ultrasonic supply cable/conductor 192. The electrical contact assembly 190 may further comprise a negative slip ring contact 194 that is mounted within handpiece housing 116 for rotatable contact with the negative electrode 136. The negative slip ring contact 194 is electrically coupled to the ultrasonic generator module 180 by a negative ultrasonic supply cable 195. It will be appreciated that such arrangement enables the acoustic assembly 124 to freely rotate relative to the ultrasonic generator module 180 while remaining in full electrical contact therewith.

[0048] In various embodiments, the ultrasonic transmission waveguide 147 may comprise a plurality of stabilizing silicone rings or compliant supports (not shown) positioned at, or at least near, a plurality of nodes. As was discussed above, the silicone rings can dampen undesirable vibration and isolate the ultrasonic energy from the sheath 158 that at least partially surrounds the waveguide 147, thereby assuring the flow of ultrasonic energy in a longitudinal direction to the distal end 152 of the end effector 150 with maximum efficiency.

[0049] As shown in FIGS. 2 and 3, the sheath 158 can be coupled to a rotation wheel 159 that is rotatably attached to the distal end of the handpiece assembly 160. The rotation wheel 159 facilitates selective rotation of the sheath 158 and the waveguide 147 relative to the handpiece assembly 160. The sheath 158 may have an adapter portion 162 that may be threaded or snapped onto the rotation wheel 159. The rotation wheel 159 may include a flanged portion (not shown) that is snapped into an annular groove in the handpiece assembly 160 to facilitate rotation of the sheath 158 and waveguide 146 relative to the handpiece assembly 160 about axis A-A. In one embodiment, the sheath 158 also includes a hollow tubular portion 164 through which the waveguide 146 extends in the manner described in further detail above. In various embodiments, the adapter 162 of the sheath 158 may be constructed from ULTEM®, for example, and the tubular portion 164 may be fabricated from stainless steel, for example. In at least one embodiment, the ultrasonic transmission waveguide 147 may have polymeric material, for example, surrounding it in order to isolate it from outside contact.

[0050] In the embodiment, as shown in FIG. 1, the ultrasonic generator module 180 is electrically coupled to the electronic signal/radio frequency generator 112 by the cables 139, 141 which may be housed in a sheath to form the cable 142. Because the acoustic assembly 124 can freely rotate relative to the ultrasonic generator module 180, the waveguide 147 and the end effector 150 may be freely rotated about axis A-A relative to the handpiece assembly 160 without causing the cable 142 to undesirably twist and tangle.

[0051] As illustrated in FIGS. 2 and 3, the handpiece assembly 160 may have a pistol grip configuration and operably support a movable trigger assembly 145 that is pivotally supported within the handpiece assembly 160. To facilitate easy assembly, the handpiece assembly 160 may comprise two housing segments 162 that are coupled together by threaded fasteners, snap features, adhesive. The movable trigger assembly 145 includes a trigger portion 153 that has a pair of spaced attachment arms 154 that each has a hole 155 therethrough. Holes 155 are each sized to receive a corresponding pivot pin (not shown) that protrudes from each of the housing segments 162. Such arrangement permits the trigger portion 153 to pivot relative to the handpiece assembly 160 about an axis that is substantially transverse to axis A-A.

[0052] As shown in FIGS. 2 and 3, the trigger assembly 145 may comprise an actuation arm 156 that is attached to the trigger portion 153 via an intermediate link 157. The actuation arm 156 is pivotally coupled (pinned) to the trigger yoke 185. The arm 156 has a mounting pin 186 extending transversely therethrough that is sized to be slidably received in corresponding elongated cavities 187 formed in the housing segments 162. See FIGS. 2 and 3. Such arrangement facilitates the axial movement of the actuation arm 156 within the handpiece assembly 160 in response to pivoting the trigger portion 153.

[0053] In the embodiment illustrated in FIG. 1, the end effector 150 portion of the surgical system 100 comprises a clamp arm assembly 149 connected at a distal end of the surgical instrument 110. The blade 146 forms a first (e.g., energizing) electrode and the clamp arm assembly 149 comprises an electrically conductive portion that forms a second (e.g., return) electrode. The signal generator module 102 is coupled to the blade 146 and the clamp arm assembly 149 through a suitable transmission medium such as a cable 137. The cable 137 comprises multiple electrical conductors for applying a voltage to the tissue and providing a return path for current flowing through the tissue back to the signal generator module 102. In various embodiments, the signal generator module 102 may be formed integrally with the generator 112 or may be provided as a separate circuit coupled to the generator 112 and, in one embodiment, may be formed integrally with the ultrasonic generator module 180 (shown in phantom to illustrate these options).

[0054] In one embodiment, the surgical system 100 illustrated in FIG. 1 may comprise components for selectively energizing an end effector 150 and transmitting mechanical energy thereto and, in addition, selectively energizing the end effector 150 with therapeutic and/or subtherapeutic electrical energy. The surgical instrument 110 may be switchable between a first operating mode in which mechanical energy, or vibrations at ultrasonic frequencies (e.g., 55.5 kHz), are transmitted to the end effector 150 and a second operating mode in which electrical energy (e.g., therapeutic and/or subtherapeutic), or current, is permitted to flow through the end effector 150. In certain embodiments, referring to FIG. 1, in a first operating mode of the surgical instrument 110, for example, the transducer 114 converts electrical energy supplied thereto by the ultrasonic generator module 180 (e.g., an ultrasonic oscillator) of the generator 112 into mechanical vibrations and transmit the vibrations into a waveguide 147 to the blade 146 portion of the end effector 150, for example. Such mechanical vibrations can be generated at ultrasonic frequencies, although any suitable frequency, or frequencies, can be used. In the second operating mode of the surgical instrument 110, an electrical current may be supplied by the generator 112 that can flow through the transducer 114, the waveguide 147, and the end effector 150. The current flowing through the waveguide 147 and end effector 150 can be an alternating current (AC current), wherein, in various embodiments, the wave form of the AC current can be sinusoidal and/or may comprise a series of step intervals, for example.

[0055] In one embodiment, the current supplied by the signal generator module 102 is an RF current. In any event, the surgical instrument 110 may comprise a supply path and a return path, wherein the tissue T (FIG. 5) being treated completes, or closes, an electrical circuit, or loop, comprising a supply path through the transducer 114, the waveguide 147, and the blade 146 and a return path through conductor cable 137. In one embodiment, the patient can be positioned on a conductive pad wherein the current can flow from a supply path of the surgical instrument, through the patient, and into the conductive pad in order to complete the electrical circuit.

[0056] Still referring to FIG. 1, as previously discussed, in one embodiment the surgical instrument 110 may be energized by the generator 112 by way of the foot switch 144 in order to energize the end effector 150. When actuated, the foot switch 144 triggers the generator 112 to deliver electrical energy to the handpiece assembly 160, for example. Although the foot switch 144 may be suitable in many circumstances, other suitable switches can be used. In various embodiments, the surgical instrument system 110 may comprise at least one supply conductor 139 and at least one return conductor 141, wherein current can be supplied to handpiece assembly 160 via the supply conductor 139 and wherein the current can flow back to the generator 112 via return conductor 141. In various embodiments, the supply conductor 139 and the return conductor 141 may comprise insulated wires and/or any other suitable type of conductor. In certain embodiments, as described below, the supply conductor 139 and the return conductor 141 may be contained within and/or may comprise a cable extending between, or at least partially between, the generator 112 and the transducer 114 portion of the handpiece assembly 160. In any event, the generator 112 can be configured to apply a sufficient voltage differential between the supply conductor 139 and the return conductor 141 such that sufficient current can be supplied to the transducer 114.

[0057] In various embodiments, still referring to FIG. 1, the supply conductor 139 and the return conductor 141 may be operably connected to a transducer drive unit 135, wherein the drive unit 135 can be configured to receive current from the generator 112 via the supply conductor 139. In certain embodiments, the handpiece assembly 160 may comprise a switch, such as a toggle switch 143, for example, which can be manipulated to place the surgical instrument 110 in one of a first operating mode and a second operating mode. In one embodiment, as described below, the toggle switch 143 may comprise a first toggle button 143a which can be depressed to place the surgical instrument 110 in the first operating mode and, in addition, a second toggle button 143b which can be depressed to place the surgical instrument in the second operating mode. Although a toggle switch is illustrated and described herein, any suitable switch, or switches, can be used. When the first toggle button 143a is depressed, the transducer drive unit 135 can operate a transducer, such as the transducer 114, for example, such that the transducer 114 produces vibrations. The transducer 114 may comprise one or more piezoelectric elements 132, wherein the drive unit 135 can be configured to apply a voltage differential, and/or a series of voltage differentials, across the piezoelectric elements 132 such that they mechanically vibrate in a desired manner. Also, the transducer 114 may comprise one or more electrodes, such as a positive electrode 134 and a negative electrode 136, for example, positioned intermediate and/or adjacent to the piezoelectric elements 132. In one embodiment, the surgical instrument 110 may comprise a positive polarizing conductor 192 operably connected to the drive unit 135 and a positive electrode 134 and, in addition, a negative polarizing conductor 195 operably connected to the drive unit 135 and the negative electrode 136, wherein the drive unit 135 can be configured to polarize the electrodes 134, 136 via the polarizing conductors 192, 195, respectively.

[0058] In various embodiments, the transducer 114 may comprise a fore-bell 122 and a velocity transformer 128 which can be configured to conduct the vibrations produced by the piezoelectric elements 132 into the transmission waveguide 147. In certain embodiments, referring still to FIG. 1, the transmission waveguide 147 may comprise an elongate shaft portion surrounded, or at least partially surrounded, by a sheath 158, for example, wherein the waveguide 147 may comprise a distal end 152. The distal end 152 of the waveguide 147 may comprise part of the end effector 150, wherein the end effector 150 may comprise the clamp member 151 having a rotatable clamp arm, or jaw, which can be pivoted between an open position in which tissue can be positioned intermediate the blade 146 and the clamp member 151 and a closed position in which clamp member 151 can position and/or compress the tissue T (FIG. 5) against the blade 146. In various embodiments, a surgical instrument may comprise a lever or actuator, such as a jaw closure trigger 145, for example, which can be actuated by a surgeon in order to pivot the clamp member 151 between its open and closed positions. In at least one embodiment, the jaw closure trigger 145 can be operably engaged with a push/pull rod operably engaged with the clamp member 151 wherein, when the jaw closure trigger 145 is closed or moved toward the handpiece assembly 160, the closure trigger 145 can push the push/pull rod distally and pivot the clamp member 151 toward the blade 146 into its closed position. Correspondingly, the jaw closure trigger 145 can be pivoted into its open position in order to pull the rod proximally and pivot the clamp member 151 away from the blade 146 into its open position.

[0059] In any event, once the tissue T (FIG. 5) has been suitably positioned within the jaws of the end effector 150, the transducer 114 can be operated by the drive unit 135 in order to transmit mechanical energy, or vibrations, into the targeted tissue T. In some embodiments, the actuation of the foot switch 144 may be sufficient to actuate the transducer 114. In certain other embodiments, the actuation of a different switch may be required in addition to or in lieu of the actuation of the foot switch 144. In one embodiment, the actuation of the foot switch 144 can supply power to the drive unit 135, although the actuation of the jaw closure trigger 145, and the trigger closure switch 147, may be required before the drive unit 135 can drive the transducer 114. In various embodiments, the jaw closure trigger 145 can be moved between a first, or open, position in which the trigger closure switch 147 is in an open state, or condition, and a second, or closed, position in which the trigger closure switch 147 is in a closed state, or condition. When the trigger closure switch 147 is in its closed condition, in various embodiments, a circuit within the drive unit 135, for example, can be closed such that the drive unit 135 can drive the transducer 114.

[0060] Referring still to FIG. 1, In various applications, a surgeon may desire to treat tissue using mechanical energy, or vibrations, transmitted through the blade 146, for example. In various other applications, the surgeon may desire to treat the tissue using therapeutic electrical energy transmitted through the blade 146. In various other applications, the surgeon may desire to obtain feedback in regards to a state of the tissue T (FIG. 5) by measuring the electrical properties of the tissue T (e.g., impedance) using subtherapeutic electrical energy transmitted through the blade 146. In various embodiments, the toggle switch 143 can be manipulated to place the surgical instrument 110 in the second operating mode. In at least one such embodiment, the second toggle button 143b of the toggle switch 143 can be depressed in order to switch the surgical instrument 110 from the first operating mode into the second operating mode. As described below, the depression of the second toggle button 143b can configure the handpiece assembly 160 such that the drive unit 135 does not drive the transducer 114 but rather, the power supplied to the handpiece assembly 160 from generator 112 can flow into the blade 146 without being converted into mechanical energy, or vibrations. In one embodiment, referring now to FIG. 5, the distal end 152 of the blade 146 can be positioned against the targeted tissue “T” and, in addition, the distal end 153 of the clamp member 151 can also be positioned against the tissue T such that current can flow from the supply conductor 139 into the blade 136, through the tissue T, and return back to the generator 112 via the clamp member 151, the return conductors 137, 141. As shown in FIG. 5, the clamp member 151 can be configured such that it is not in contact with the blade 146 when the clamp member 151 is in the closed position.

[0061] With reference now back to FIG. 1, in various embodiments, the return conductor 137 may comprise an insulated wire having a first end operably coupled with the clamp member 151 and a second end operably coupled with the return conductor 141, wherein current can flow through the return conductor 137 when the toggle switch 143 is in the second configuration and the trigger closure switch 147 has been closed by the trigger 145. In one embodiment, current will not flow through the return conductor 137 when the trigger closure switch 147 is in an open condition and/or when the toggle switch 143 is in the first configuration, i.e., when the first toggle button 143a is depressed, as described above. In any event, in various circumstances, the current flowing through the tissue T (FIG. 5) from the distal end 152 of the blade 146 to the distal end 153 of the clamp member 151 can treat the tissue positioned intermediate, and/or surrounding, the distal ends 152, 153. In another embodiment, the current may be subtherapeutic for measuring the electrical state of the tissue T (FIG. 5).

[0062] The distal end 152 of the blade 146 may comprise a supply electrode while the distal end 153 of the clamp member 151 may comprise a return electrode. In various other embodiments, current can be supplied to the conductor 137 such that the distal end 153 of the clamp member 151 may comprise the supply electrode and the distal end 152 of the blade 146 may comprise the return electrode. In one embodiment, the current can return to the generator 112 via the blade 146, the waveguide 147, and the conductor 139. In either event, referring again to FIG. 1, at least a portion of the return conductor 137 can extend along the outside of the sheath 158, wherein at least another portion of the return conductor 137 can extend through the handpiece assembly 160. In certain embodiments, although not illustrated, at least a portion of the return conductor 137 can be positioned within the sheath 158 and can extend alongside the blade 146.

[0063] As shown in FIG. 6, in some embodiments, the surgical instrument 110 may comprise an inner sheath 257 and an outer sheath 258, wherein the inner sheath 257 can define a first, or inner, passageway 259, and wherein the inner sheath 257 and the outer sheath 258 can define a second, or outer, passageway 261 therebetween. In one embodiment, the blade 146 can extend through the inner passageway 259 and the return conductor 137, and/or any other suitable conductor, can extend through the outer passageway 261. In various other embodiments, a conductor can be embedded in at least a portion of the inner sheath 257 or the outer sheath 258.

[0064] As shown in FIG. 7, in one embodiment, a sheath may comprise a non-electrically conductive or insulative material 358, such as plastic and/or rubber, for example, overmolded onto a conductive insert 357, which can be comprised of copper, for example, wherein the conductive insert 357 can allow current flowing through the blade 146 to return to the generator 112 after it has passed through the targeted tissue T (FIG. 5) as described above. In various embodiments, the insulative material 358 can entirely, or at least substantially, surround the conductive insert 357 such that current flowing through the conductive insert 357 does not unintentionally short to non-targeted tissue, for example. In at least one embodiment, the insulative material 358 can cover the inside surface and the outside surface of the conductive insert 357. In certain embodiments, although not illustrated, an insulative material of a sheath may cover only the outer surface of a conductive insert, for example.

[0065] In various embodiments, as described above, a first end of the return conductor 137 can be operably coupled to the clamp member 151 such that current can flow therethrough. In certain embodiments, the first end of the return conductor 137 can be soldered and/or welded to the clamp member 151. In one embodiment, although not illustrated, the clamp member 151 may comprise an aperture configured to receive the first end of the return conductor 137 wherein a fastener can be inserted into the aperture in order to secure the first end therein. In at least one such embodiment, the sidewalls of the aperture can be at least partially threaded and the fastener can be threadably received in the threaded aperture.

[0066] As shown in FIG. 8, in one embodiment, a clamp arm assembly 451 may comprise a conductive jacket 472 mounted to a base 449. In one embodiment, the first end of the return conductor 137 may be mounted to the conductive jacket 472 such that current can flow from the blade 146, through tissue positioned intermediate the jacket 472 and the blade 146, and then into the jacket 472 and to the return conductor 137. In various embodiments, the conductive jacket 472 may comprise a center portion 473 and at least one downwardly-extending sidewall 474 which can extend below bottom the surface 475 of the base 449. In the illustrated embodiment, the conductive jacket 472 has two sidewalls 474 extending downwardly on opposite sides of the base 449. In certain embodiments, the center portion 473 may comprise at least one aperture 476 which can be configured to receive a projection 477 extending from the base 449. In one embodiment, the projections 477 can be press-fit within the apertures 476 in order to secure the conductive jacket 472 to the base 449 although, in some embodiments, the projections 477 can be deformed after they have been inserted into the apertures 476. In various embodiments, fasteners can be used to secure the conductive jacket 472 to the base 449.

[0067] In various embodiments, the clamp arm assembly 451 may comprise a non-electrically conductive or insulative material, such as plastic and/or rubber, for example, positioned intermediate the conductive jacket 472 and the base 449. The insulative material can prevent current from flowing, or shorting, between the conductive jacket 472 and the base 449. In various embodiments, referring again to FIG. 8, the base 449 may comprise at least one aperture 478, for example, which can be configured to receive a pivot pin (not illustrated), wherein the pivot pin can be configured to pivotably mount the base 449 to the sheath 158, for example, such that the clamp arm assembly 451 can be rotated between open and closed positions relative to the sheath 158. In the embodiment illustrated in FIG. 8, the base 449 includes two apertures 478 positioned on opposite sides of the base 449. In one embodiment, the pivot pin can be comprised of a non-electrically conductive or insulative material, such as plastic and/or rubber, for example, which can be configured to prevent current from flowing into the sheath 158 even if the base 449 is in electrical contact with the conductive jacket 472, for example.

[0068] In various embodiments, as described above, the surgical instrument system 110 can be configured such that current can flow from the distal tip of the blade 146, through the tissue T (FIG. 5), and then to the distal tip of the clamp member 151. In one embodiment, as shown in to FIG. 5, the clamp member 151 may comprise a tissue engaging pad or clamp pad 155, for example, mounted thereto, wherein the pad 155 can be configured to contact tissue positioned intermediate the clamp member 151 and the waveguide 146. In one expression of the embodiment, the pad 155 may be formed of a non-electrically conductive or insulative material, such as polytetrafluoroethylene (PTFE), such as for example TEFLON® a trademark name of E. I. Du Pont de Nemours and Company, a low coefficient of friction polymer material, or any other suitable low-friction material. The non-electrically conductive or insulative material can also server to prevent current from flowing between the clamp member 151 and the blade 146 without first passing through the distal end 152 of the blade 146, the targeted tissue T, and the distal end 153 of the clamp member 151. In various embodiments, the pad 155 can be attached to the clamp member 151 utilizing an adhesive, for example. The clamp pad 155 mounts on the clamp member 151 for cooperation with the blade 146, with pivotal movement of the clamp member 151 positioning the clamp pad 155 in substantially parallel relationship to, and in contact with, the blade 146, thereby defining a tissue treatment region. By this construction, tissue is grasped between the clamp pad 155 and the blade 146. The clamp pad 155 may be provided with a non-smooth surface, such as a saw tooth-like configuration to enhance the gripping of tissue in cooperation with the blade 146. The saw tooth-like configuration, or teeth, provide traction against the movement of the blade 146. The teeth also provide counter traction to the blade 146 and clamping movement. It will be appreciated that the saw tooth-like configuration is just one example of many tissue engaging surfaces to prevent movement of the tissue relative to the movement of the blade 146. Other illustrative examples include bumps, criss-cross patterns, tread patterns, a bead, or sand blasted surface.

[0069] In various other embodiments, the surgical instrument 110 can be configured such that current can flow through tissue clamped between the blade 146, for example, and the clamp member 151 without having to first pass through the distal ends thereof. In at least one embodiment, referring now to FIG. 9, a clamp arm assembly 551 may comprise an electrically-conductive member 572 and a pad 555 attached thereto, wherein the electrically-conductive member 572 may comprise at least one sidewall 574 extending downwardly therefrom. In one embodiment, current can flow between the blade 146, for example, through tissue positioned between the blade 146 and the sidewalls 574 of the clamp arm assembly 551, and into the sidewalls 574. In various embodiments, gaps can be defined between each sidewall 574 and the blade 146 and, in addition, a gap can be defined between the tissue-contacting surface 575 of the pad 555 and the blade 146.

[0070] In one embodiment, referring now to FIG. 10, the gaps between each sidewall 574 and the waveguide 146 can be defined by a distance “D1,” wherein the distance D1 can be selected such that, when the clamp arm assembly 551 is positioned in a closed position, the tissue positioned intermediate each of the sidewalls 574 and the blade 146 can be compressed. Although these gaps are illustrated as having the same distance D1, other embodiments are envisioned in which the gaps have different distances. A gap between the tissue-contacting surface 575 and the blade 146 can be defined by a distance “D2,” wherein the distance D2 also may be selected such that, when the clamp arm assembly 551 is positioned in a closed position, the tissue-contacting surface 575 can be contact and/or compress the tissue against blade 146.

[0071] In various embodiments, a clamp arm assembly may comprise an electrically-conductive pad mounted thereto. In at least one such embodiment, such a pad can be configured to contact and/or compress tissue positioned intermediate the clamp arm assembly and a waveguide, such as the blade 146, for example, such that current can flow from the blade 146 into the pad. In certain embodiments, the electrically conductive pad can be comprised of a typically conductive material, such as copper, for example. In at least one embodiment, the pad can be comprised of a typically non-conductive material, such as PTFE, for example, which can be impregnated with electrically conductive particles, such as medical grade stainless steel, for example, such that the pad is sufficiently conductive to permit current to flow between the blade 146 and the clamp arm.

[0072] In one embodiment, as previously discussed, the surgical instrument 110 comprises the blade 146, for example, which may comprise a first electrode and, in addition, a clamp arm, such as the clamp member 151, for example, which may comprise a second electrode. In various embodiments, as also discussed above, the blade 146 may comprise a supply electrode whereas the clamp member 151 may comprise a return electrode. Alternatively, the clamp member 151 may comprise the supply electrode while the blade 146 may comprise the return electrode. In various other embodiments, a clamp arm may comprise both the supply electrode and the return electrode. In certain embodiments, referring now to FIG. 11, a clamp arm may comprise a pad 655 and two or more electrodes, such as a first electrode 682 and a second electrode 683, for example. In one embodiment, the pad 655 can be comprised of a non-electrically conductive or insulative material, such as PTFE, for example, as previously discussed with reference to the clamp pad 155 (FIG. 5), whereas the electrodes 682, 683 can be comprised of an electrically conductive material, such as copper and/or a PTFE material having electrically conductive particles mixed therein, for example. In various embodiments, the first electrode 682 and/or the second electrode 683 can be embedded within the pad 655. In at least one such embodiment, the pad 655 can be molded onto the electrodes 682, 683 whereas, in certain embodiments, the electrodes 682, 683 can be inserted and/or press-fit into openings formed in the pad 655.

[0073] In various embodiments, the first electrode 682 can be positioned adjacent to a first side 674a of the pad 655 while the second electrode 683 can be positioned adjacent to a second side 674b of the pad 655. In use, the first electrode 682 may comprise a supply electrode and the second electrode 683 may comprise a return electrode, wherein current can flow from the supply electrode 682, through tissue clamped or positioned between the pad 655 and the blade 146, for example, and into the return electrode 683. In one embodiment, a supply wire can be operably coupled with the first electrode 682 and a return wire can be operably coupled with the second electrode 683 such that current can be supplied thereto from a power source, such as the generator 112, for example. In various embodiments, referring still to FIG. 11, the electrodes 682, 683 can be positioned within the pad 655 such that the electrodes 682, 683 do not contact the blade 146 when the clamp member 151 (FIG. 5) is in a closed position and short to the blade 146. Although the illustrated embodiment comprises one supply electrode and one return electrode positioned within a pad, embodiments are envisioned in which a pad includes more than one supply electrode and/or more than one return electrode.

[0074] As discussed above, electrodes can be embedded within the pad of a clamp arm assembly. In various embodiments, first and second electrodes can be mounted to the sides of a clamp arm pad. Referring now to FIG. 12, a clamp arm may comprise a pad 755, for example, which can be configured to hold tissue against the blade 146, for example, wherein a first electrode 782 can be mounted to a first side 774a of the pad 755 and wherein a second electrode 783 can be mounted to a second side 774b of the pad 755. In various embodiments, the electrodes 782, 783 can be positioned within cut-outs in the sides of the pad 755 wherein, in certain embodiments, the electrodes 782, 783 can be adhered and/or fastened, for example, to the pad 755. The first electrode 782 may comprise a supply electrode and the second electrode 783 may comprise a return electrode, wherein current can flow from the supply electrode 782, through tissue clamped or positioned between the pad 755 and the blade 146, for example, and into the return electrode 783. In one embodiment, a supply wire can be operably coupled with the first electrode 782 and a return wire can be operably coupled with the second electrode 783 such that current can be supplied thereto from a power source, such as the generator 112, for example. Furthermore, the electrodes 782, 783 can be mounted to the pad 755 such that the electrodes 782, 783 do not contact the blade 146 and create an electrical short thereto. Although the illustrated embodiment comprises one supply electrode and one return electrode mounted to a pad, embodiments are envisioned in which a pad includes more than one supply electrode and/or more than one return electrode.

[0075] Still referring to FIG. 12, various electrodes can be configured such that they extend in a longitudinal direction which is parallel, or at least substantially parallel, to the longitudinal axis of the blade 146, for example. In various embodiments, the electrodes can extend along an end effector such that the entire length of the tissue positioned within the end effector can be treated. In various embodiments, referring now to FIG. 13, a clamp arm may comprise a pad 885 having two point electrodes. More particularly, in one embodiment, the pad 855 may comprise a first point electrode 882 and a second point electrode 883 positioned therein, wherein current can flow through tissue positioned intermediate the first point electrode 882 and the second point electrode 883. In at least one such embodiment, the pad 855 can be comprised of a non-electrically conductive material, the first point electrode 882 may comprise a supply electrode, and the second point electrode 883 may comprise a return electrode. In various embodiments, the electrodes 882, 883 can be embedded within the pad 885 and, in one embodiment the pad 885 can be molded around the electrodes 882, 883. In certain embodiments, the electrodes 882, 883 can be inserted into apertures within the pad 855. A supply wire can be operably coupled with the first electrode 882 and a return wire can be operably coupled with the second electrode 883 such that current can be supplied thereto from a power source, such as the generator 112, for example. Furthermore, the electrodes 882, 883 can be positioned within the pad 855 such that the electrodes 882, 883 do not contact the blade 146 and create an electrical short thereto. In one embodiment, the clamp arm supporting pad 885, and/or a sheath rotatably supporting the clamp arm, may further comprise a stop which can be configured to prevent the pad 855 from rotating into a position in which the electrodes 882, 883 contact the blade 146. Although the illustrated embodiment comprises one supply point electrode and one return point electrode positioned within a pad, other embodiments are envisioned in which a pad includes more than one supply point electrode and/or more than one return point electrode. Various embodiments are envisioned in which a pad includes an array of supply point electrodes and/or an array of return point electrodes.

[0076] In various embodiments, as described above, a surgical instrument may comprise a clamp arm including both a supply electrode and a return electrode. In one embodiment, the surgical instrument may comprise a waveguide which does not comprise an electrode. In certain embodiments, a supply electrode and a return electrode can be configured such that current can flow therebetween along a predetermined path. In various embodiments, such a path can be one-dimensional. Embodiments having two point electrodes, for example, can permit such a path. In other embodiments, such a path can be two-dimensional. Embodiments having an array of point electrodes, for example, can permit such a path. A two-dimensional path can be referred to as a field. In certain embodiments, a path can be three-dimensional. In at least one such embodiment, a clamp arm assembly can have a supply electrode and a return electrode while the waveguide may comprise one of a supply electrode or a return electrode. In embodiments where the waveguide comprises a return electrode, current can flow from the supply electrode of the clamp arm assembly to the return electrode of the clamp arm assembly and the return electrode of the waveguide. In one such embodiment, the return electrodes may comprise a common ground. In embodiments where the waveguide comprises a supply electrode, current can flow from the waveguide and the supply electrode of the clamp arm assembly to the return electrode of the clamp arm assembly. Such arrangements can permit the current to flow in a three-dimensional path, or field.

[0077] In various embodiments, referring now to FIG. 14, the surgical instrument 110 may comprise a sheath encompassing, or at least partially encompassing, a portion of the blade 146 wherein a sheath may comprise both at least one supply conductor and at least one return conductor. In one embodiment, a sheath may comprise a plurality of conductive inserts, such as a first conductive insert 957a and a second conductive inserts 957b, for example, wherein the first conductive insert 957a may comprise a supply conductor and wherein the second conductive insert 957b may comprise a return conductor. In various embodiments, a non-electrically conductive or insulative material 958, such as plastic and/or rubber, for example, can be overmolded onto the first and second conductive inserts 957a, 957b in order to comprise the sheath. In various other embodiments, the surgical instrument 110 may comprise, referring now to FIG. 15, a sheath assembly encompassing, or at least partially encompassing, a portion of a waveguide wherein the sheath assembly may comprise an inner sheath, such as an inner sheath 1057, for example, and an outer sheath, such as an outer sheath 1058, for example. In one embodiment, the inner sheath 1057 may comprise a supply conductor operably coupled with a supply electrode in a clamp arm assembly, wherein the outer sheath 1058 may comprise a return conductor operably coupled with a return electrode in the clamp arm assembly. In certain embodiments, the inner sheath 1057 and/or the outer sheath 1058 may be comprised of an electrically conductive material, such as medical grade stainless steel, for example, wherein, in one embodiment, one or more surfaces of the inner sheath 1057 and/or the outer sheath 1058 can be coated, or at least partially coated, in a non-conductive material, such as a material comprising poly(p-xylylene) polymers, for example. Materials comprised of poly(p-xylylene) polymers are often sold under the tradename of Parylene™.

[0078] In various embodiments, a clamp arm can be moved between open and closed positions in order position and/or compress tissue T against a blade. In one embodiment, referring to FIG. 16, a clamp arm 1151 may comprise a base 1149 and a pad 1155 mounted to the base 1149, wherein the pad 1155 can be configured to contact and compress tissue T against the blade 146, for example. As illustrated in FIG. 16, the pad 1155 may comprise a tissue-contacting surface 1175 which, although it may include various serrations, ridges, and/or surface texturing, is planar, or at least substantially planar. In such embodiments, especially when the blade 146 has a round or arcuate cross-section, only a small portion of the tissue T positioned intermediate the blade 146 and the pad 1155 may contact the surface area, or perimeter, of the blade 146. As illustrated in FIG. 16, the tissue T may contact the blade 146 at a contact point P. Various alternative embodiments are envisioned in which the clamp arm 1251, for example, may comprise downwardly-extending sidewalls 1274 which extend below a tissue-contacting surface 1275 of the pad 1255, for example, although a clamp arm may comprise a tissue-contacting surface with or without a pad. In one embodiment, referring to FIG. 17, the sidewalls 1274 can be configured to contact the tissue T positioned laterally with respect to the blade 146 and push the tissue T downwardly. As illustrated in FIG. 17, the sidewalls 1274 can push the tissue T downwardly such that the tissue T positioned intermediate the sidewalls 1274 contacts a larger surface area, or perimeter, on the blade 146 as compared to the embodiment illustrated in FIG. 16. Owing to the larger contact area, the blade 146 may be more efficient in cutting, coagulating, and/or otherwise treating the tissue. In embodiments where the blade 146 may comprise a circular or arcuate cross-section, the perimeter contact distance, i.e., the distance in which the tissue is in contact with the perimeter of the blade 146, may comprise an arclength (s) which can equal the product of the radius of curvature of the arc R and the sweep angle θ defined between the two contact points P. As illustrated in FIG. 17, the contact points P can represent the endpoints of the perimeter in which the tissue T contacts the blade 146. Although the illustrated blade 146 is depicted as having a curved or arcuate cross-section, any other suitable cross-section may be used.

[0079] In various embodiments, the tissue-contacting surface 1275 of the clamp arm 1251 can define a plane 1298 which can represent the portions of the pad 1255 which contact the tissue T positioned within the end effector when the clamp arm 1251 is rotated between its open and closed positions. As illustrated in FIG. 17, the sidewalls 1274 of the clamp arm 1251 can extend through the plane 1298, wherein, when the clamp arm 1251 is rotated from an open position into a closed position, the sidewalls 1274 can be positioned laterally along the opposite sides of the blade 146 and, in addition, the tissue-contacting surface 1275 can be positioned against, or adjacent to, the top surface of the blade 146 such that the plane 1298 is aligned with, or respect to, a plane 1299 extending through the top surface of the blade 146. In one embodiment, the plane 1299 can be defined as a tangential plane which is tangential to the perimeter of the blade 146. In one embodiment, the plane 1299 can be tangential to the top tissue-contacting surface of the blade 146, for example, wherein the top tissue-contacting surface of the 146 may comprise the surface closest to the clamp tissue-contacting surface 1275 when the clamp arm 1271 is in its closed position. In the illustrated embodiment, still referring to FIG. 17, the planes 1298, 1299 can be parallel, or at least substantially parallel, to one another when the tissue-contacting surface 1275 is positioned adjacent to the blade 146, while the planes 1298, 1299 can be co-planar, or at least substantially co-planar, with one another when the tissue-contacting surface 1275 is in contact with the blade 146. The sidewalls 1274 can be sized and configured such that they extend through the blade plane 1299 when the clamp arm 1271 is in the closed position. In various embodiments, the sidewalls 1274 may not extend through the plane 1299 when the clamp arm 1251 is in the open position. In one embodiment, the sidewalls 1274 may “break” the plane 1299 as the clamp arm 1251 is being closed, but before it is completely closed. In one embodiment, the sidewalls 1274 may break the plane 1299 just before the clamp arm 1251 reaches its completely closed position.

[0080] FIG. 18 illustrates one embodiment of a drive system 32 of the ultrasonic generator module 180 shown in FIG. 1, which creates an ultrasonic electrical signal for driving an ultrasonic transducer. With reference now to FIGS. 1 and 18, the drive system 32 is flexible and can create an ultrasonic electrical drive signal 416 at a desired frequency and power level setting for driving the ultrasonic transducer 114. In various embodiments, the generator 112 may comprise several separate functional elements, such as modules and/or blocks. Although certain modules and/or blocks may be described by way of example, it can be appreciated that a greater or lesser number of modules and/or blocks may be used and still fall within the scope of the embodiments. Further, although various embodiments may be described in terms of modules and/or blocks to facilitate description, such modules and/or blocks may be implemented by one or more hardware components, e.g., processors, Digital Signal Processors (DSPs), Programmable Logic Devices (PLDs), Application Specific Integrated Circuits (ASICs), circuits, registers and/or software components, e.g., programs, subroutines, logic and/or combinations of hardware and software components.

[0081] In one embodiment, the ultrasonic generator module 180 drive system 32 may comprise one or more embedded applications implemented as firmware, software, hardware, or any combination thereof. The ultrasonic generator module 180 drive system 32 may comprise various executable modules such as software, programs, data, drivers, application program interfaces (APIs), and so forth. The firmware may be stored in nonvolatile memory (NVM), such as in bit-masked read-only memory (ROM) or flash memory. In various implementations, storing the firmware in ROM may preserve flash memory. The NVM may comprise other types of memory including, for example, programmable ROM (PROM), erasable programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM), or battery backed random-access memory (RAM) such as dynamic RAM (DRAM), Double-Data-Rate DRAM (DDRAM), and/or synchronous DRAM (SDRAM).

[0082] In one embodiment, the ultrasonic generator module 180 drive system 32 comprises a hardware component implemented as a processor 400 for executing program instructions for monitoring various measurable characteristics of the ultrasonic surgical instrument 110 and generating a corresponding output control signal for operating the surgical instrument 110. In various embodiments, the output control signal is for driving the ultrasonic transducer 114 in cutting and/or coagulation operating modes, measuring electrical characteristics of the surgical instrument 110 and/or the tissue T, and providing feedback to use. It will be appreciated by those skilled in the art that the ultrasonic generator module 180 and the drive system 32 may comprise additional or fewer components and only a simplified version of the ultrasonic generator module 180 and the drive system 32 are described herein for conciseness and clarity. In various embodiments, as previously discussed, the hardware component may be implemented as a DSP, PLD, ASIC, circuits, and/or registers. In one embodiment, the processor 400 may be configured to store and execute computer software program instructions to generate the step function output signals for driving various components of the ultrasonic surgical instrument 110, such as the transducer 114, the end effector 150, and/or the blade 146.

[0083] In one embodiment, under control of one or more software program routines, the processor 400 executes the methods in accordance with the described embodiments to perform a variety of functions, such as, for example, generating a step function formed by a stepwise waveform of drive signals comprising current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T), driving the ultrasonic transducer 114, driving the end effector 150 using therapeutic and/or subtherapeutic electrical signals (e.g., RF signal), measuring the impedance (Z) of the transducer 114, measuring the impedance (Z_t) of the tissue T, and/or providing feedback to the user. In one embodiment, stepwise waveforms of the drive signals may be generated by forming a piecewise linear combination of constant functions over a plurality of time intervals created by stepping the ultrasonic generator module 180 drive signals, e.g., output drive current (I), voltage (V), and/or frequency (f). The time intervals or periods (T) may be predetermined (e.g., fixed and/or programmed by the user) or may be variable. Variable time intervals may be defined by setting the drive signal to a first value and maintaining the drive signal at that value until a change is detected in a monitored characteristic. Examples of monitored characteristics may comprise, for example, transducer impedance, tissue impedance, tissue heating, tissue transection, tissue coagulation, and the like. The ultrasonic drive signals generated by the ultrasonic generator module 180 include, without limitation, ultrasonic drive signals that excite various vibratory modes of the ultrasonic transducer 114 such as the primary longitudinal mode and harmonics thereof as well flexural and torsional vibratory modes.

[0084] In one embodiment, the executable modules comprise one or more algorithm(s) 402 stored in memory that when executed causes the processor 400 to perform a variety of functions, such as, for example, generating a step function formed by a stepwise waveform of drive signals comprising current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T), driving the ultrasonic transducer 114, driving the end effector 150 using a therapeutic and/or subtherapeutic electrical signal (e.g., RF signal), measuring the impedance (Z) of the transducer 114, measuring the impedance (Z_t) of the tissue T, and/or providing feedback in accordance with a state of the tissue T. In one embodiment, an algorithm 402 is executed by the processor 400 to generate a step function formed by a stepwise waveform of drive signals comprising current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T). The stepwise waveforms of the drive signals may be generated by forming a piecewise linear combination of constant functions over two or more time intervals created by stepping the generator's 30 output drive current (I), voltage (V), and/or frequency (f). The drive signals may be generated either for predetermined fixed time intervals or periods (T) of time or variable time intervals or periods of time in accordance with the one or more stepped output algorithm(s) 402. Under control of the processor 400, the ultrasonic generator module 180 steps (e.g., increment or decrement) the current (I), voltage (V), and/or frequency (f) up or down at a particular resolution for a predetermined period (T) or until a predetermined condition is detected, such as a change in a monitored characteristic (e.g., transducer impedance, tissue impedance). The steps can change in programmed increments or decrements. If other steps are desired, the ultrasonic generator module 180 can increase or decrease the step adaptively based on measured system characteristics. In other embodiments, algorithms 402 may be executed by the processor 400 to drive the ultrasonic transducer 114, drive the end effector 150 using a therapeutic and/or subtherapeutic electrical signal (e.g., RF signal), measure the impedance (Z) of the transducer 114, measure the impedance (Z_t) of the tissue T, and/or to provide feedback in accordance with a state of the tissue T.

[0085] In operation, the user can program the operation of the ultrasonic generator module 180 using the input device 406 located on the front panel of the ultrasonic generator module 180 console. The input device 406 may comprise any suitable device that generates signals 408 that can be applied to the processor 400 to control the operation of the ultrasonic generator module 180. In various embodiments, the input device 406 includes buttons, switches, thumbwheels, keyboard, keypad, touch screen monitor, pointing device, remote connection to a general purpose or dedicated computer. In other embodiments, the input device 406 may comprise a suitable user interface. Accordingly, by way of the input device 406, the user can set or program the current (I), voltage (V), frequency (f), and/or period (T) for programming the step function output of the ultrasonic generator module 180. The processor 400 then displays the selected power level by sending a signal on line 410 to an output indicator 412.

[0086] In various embodiments, the output indicator 412 may provide visual, audible, and/or tactile feedback to the surgeon to indicate the status of a surgical procedure, such as, for example, when tissue cutting and coagulating is complete based on a measured characteristic of the ultrasonic surgical instrument 110, e.g., transducer impedance, tissue impedance, or other measurements as subsequently described. By way of example, and not limitation, visual feedback comprises any type of visual indication device including incandescent lamps or light emitting diodes (LEDs), graphical user interface, display, analog indicator, digital indicator, bar graph display, digital alphanumeric display. By way of example, and not limitation, audible feedback comprises any type of buzzer, computer generated tone, computerized speech, voice user interface (VUI) to interact with computers through a voice/speech platform. By way of example, and not limitation, tactile feedback comprises any type of vibratory feedback provided through the instrument handpiece assembly 160 or simply housing handle assembly.

[0087] In one embodiment, the processor 400 may be configured or programmed to generate a digital current signal 414 and a digital frequency signal 418. These signals 414, 418 are applied to a direct digital synthesizer (DDS) circuit 420 to adjust the amplitude and the frequency (f) of the current output signal 416 to the transducer 114. The output of the DDS circuit 420 is applied to an amplifier 422 whose output is applied to a transformer 424. The output of the transformer 424 is the signal 416 applied to the ultrasonic transducer 114, which is coupled to the blade 146 by way of the waveguide 147.

[0088] In one embodiment, the ultrasonic generator module 180 comprises one or more measurement modules or components that may be configured to monitor measurable characteristics of the ultrasonic instrument 110. In embodiment illustrated in FIG. 18, the processor 400 may be employed to monitor and calculate system characteristics. As shown, the processor 400 measures the impedance Z of the transducer 114 by monitoring the current supplied to the transducer 114 and the voltage applied to the transducer 114. In one embodiment, a current sense circuit 426 is employed to sense the current flowing through the transducer 114 and a voltage sense circuit 428 is employed to sense the output voltage applied to the transducer 114. These signals may be applied to the analog-to-digital converter 432 (ADC) via an analog multiplexer 430 circuit or switching circuit arrangement. The analog multiplexer 430 routes the appropriate analog signal to the ADC 432 for conversion. In other embodiments, multiple ADCs 432 may be employed for each measured characteristic instead of the multiplexer 430 circuit. The processor 400 receives the digital output 433 of the ADC 432 and calculates the transducer impedance Z based on the measured values of current and voltage. In response to the transducer impedance (Z), the processor 400 controls the operation of the surgical instrument 110. For example, the processor 400 can adjust the power delivered to the transducer 114, can shut off the power to the transducer 114, and/or provide feedback to the user. In one embodiment, the processor 400 adjusts the output drive signal 416 such that it can generate a desired power versus load curve. In one embodiment, in accordance with a programmed step function algorithms 402, the processor 400 can step the drive signal 416, e.g., the current or frequency, in any suitable increment or decrement in response to the transducer impedance Z.

[0089] With reference back now to FIGS. 1 and 18, to actually cause the surgical blade 146 to vibrate, e.g., actuate the blade 146, the user activates the foot switch 144 or the switch 143 on the handpiece assembly 160, as discussed above. This activation outputs the drive signal 416 to the transducer 114 based on programmed values of current (I), frequency (f), and corresponding time periods (T). After a predetermined fixed time period (T), or variable time period based on a measurable system characteristic such as changes in the impedance Z of the transducer 114, the processor 400 changes the output current step or frequency step in accordance with the programmed values. The output indicator 412 communicates the particular state of the process to the user.

[0090] The operation of the ultrasonic generator module 180 may be programmed to provide a variety of output drive signals to measure electrical properties of current, voltage, power, impedance, and frequency associated with the transducer 114 in an unloaded state, a lightly loaded state, and a heavily loaded state, for example. When the ultrasonic transducer 114 is in an unloaded state, the ultrasonic generator module 180 output may be stepped in a first sequence, for example. In one embodiment, the ultrasonic generator module 180 is initially activated at about time 0 resulting in a drive current rising to a first set point I₁of about 100 mA. The current is maintained at the first set point I1, for a first period T₁. At the end of the first period T₁, e.g., about 1 second, the current set point is changed, e.g., stepped, by the ultrasonic generator module 180 in accordance with the software, e.g., the step function algorithm(s) 402, to a second set point I₂of about 175 mA for a second period T₂, e.g., about 2 seconds. At the end of the second period T₂, e.g., at about 3 seconds, the ultrasonic generator module 180 software changes the current to a third set point I₃of about 350 mA. The voltage, current, power, and frequency respond only slightly because there is no load on the system.

[0091] When the ultrasonic transducer 114 is in a heavily loaded state, the ultrasonic generator module 180 is activated at about time 0 resulting in the current rising to the first set point I₁, of about 100 mA. At about 1 second the current set point is changed within the ultrasonic generator module 180 by the software to I₂of about 175 mA, and then again at about 3 seconds the ultrasonic generator module 180 changes the current 300 set point to I₃of about 350 mA. The voltage, current, power, and frequency respond to the heavy load.

[0092] When the ultrasonic transducer 114 is in a heavily loaded state, the ultrasonic generator module 180 is activated at about time 0 resulting in the current rising to the first set point I₁of about 100 mA. At about 1 second the current set point is changed within the ultrasonic generator module 180 by the software to I₂of about 175 mA, and then again at about 3 seconds the ultrasonic generator module 180 changes the current 300 set point to I₃of about 350 mA. The voltage, current, power, and frequency respond to the heavy load.

[0093] It will be appreciated by those skilled in the art that the current step function set points (e.g., I₁, I₂, I₃) and the time intervals or periods (e.g., T₁, T₂) of duration for each of the step function set points described above are not limited to the values described herein and may be adjusted to any suitable value as may be desired for a given set of surgical procedures. Additional or fewer current set points and periods of duration may be selected as may be desired for a given set of design characteristics or performance constraints. As previously discussed, the periods may be predetermined by programming or may be variable based on measurable system characteristics. The embodiments are not limited in this context.

[0094] Having described operational details of various embodiments of the surgical system 100, operations for the above surgical system 100 may be further described in terms of a process for cutting and coagulating a blood vessel employing a surgical instrument comprising the input device 406 and the transducer impedance measurement capabilities described with reference to FIG. 18. Although a particular process is described in connection with the operational details, it can be appreciated that the process merely provides an example of how the general functionality described herein can be implemented by the surgical system 100. Further, the given process does not necessarily have to be executed in the order presented herein unless otherwise indicated. As previously discussed, the input device 406 may be employed to program the stepped output (e.g., current, voltage, frequency) to the ultrasonic transducer 114/blade 146 assembly.

[0095] Accordingly, one technique for sealing a vessel includes separating and moving the inner muscle layer of the vessel away from the adventitia layer prior to the application of standard ultrasonic energy to transect and seal the vessel. Although conventional methods have achieved this separation by increasing the force applied to the clamp member 151, disclosed is an alternative apparatus and method for cutting and coagulating tissue without relying on clamp force alone. In order to more effectively separate the tissue layers of a vessel, for example, the ultrasonic generator module 180 may be programmed to apply a frequency step function to the ultrasonic transducer 114 to mechanically displace the blade 146 in multiple modes in accordance with the step function. In one embodiment, the frequency step function may be programmed by way of the user interface 406, wherein the user can select a stepped-frequency program, the frequency (f) for each step, and the corresponding time period (T) of duration for each step for which the ultrasonic transducer 114 will be excited. The user may program a complete operational cycle by setting multiple frequencies for multiple periods to perform various surgical procedures.

[0096] In one embodiment, a first ultrasonic frequency may be set initially to mechanically separate the muscle tissue layer of a vessel prior to applying a second ultrasonic frequency to cut and seal the vessel. By way of example, and not limitation, in accordance with one implementation of the program, initially, the ultrasonic generator module 180 is programmed to output a first drive frequency f₁for a first period T₁of time (for example less than approximately 1 second), wherein the first frequency f₁is significantly off resonance, for example, f_o/2, 2f_oor other structural resonant frequencies, where f_ois the resonant frequency (e.g., 55.5 kHz). The first frequency f₁provides a low level of mechanical vibration action to the blade 146 that, in conjunction with the clamp force, mechanically separates the muscle tissue layer (subtherapeutic) of the vessel without causing significant heating that generally occurs at resonance. After the first period T₁, the ultrasonic generator module 180 is programmed to automatically switch the drive frequency to the resonant frequency f_ofor a second period T₂to transect and seal the vessel. The duration of the second period T₂may be programmed or may be determined by the length of time it actually takes to cut and seal the vessel as determined by the user or may be based on measured system characteristics such as the transducer impedance Z as described in more detail below.

[0097] In one embodiment, the tissue/vessel transection process (e.g., separating the muscle layer of the vessel from the adventitia layer and transecting/sealing the vessel) may be automated by sensing the impedance Z characteristics of the transducer 114 to detect when the transection of the tissue/vessel occurs. The impedance Z can be correlated to the transection of the muscle layer and to the transection/sealing of the vessel to provide a trigger for the processor 400 to generate the frequency and/or current step function output. As previously discussed with reference to FIG. 18, the impedance Z of the transducer 114 may be calculated by the processor 400 based on the current flowing through transducer 114 and the voltage applied to the transducer 114 while the blade 146 is under various loads. Because the impedance Z of the transducer 114 is proportional to the load applied to the blade 146, as the load on the blade 146 increases the impedance Z of the transducer 114 increases and as the load on the blade 146 decreases the impedance Z of the transducer 114 decreases. Accordingly, the impedance Z of the transducer 114 can be monitored to detect the transection of the inner muscle tissue layer of the vessel from the adventitia layer and can also be monitored to detect when the vessel has been transected and sealed.

[0098] In one embodiment, the ultrasonic surgical instrument 110 may be operated in accordance with a programmed step function algorithm responsive to the transducer impedance Z. In one embodiment, a frequency step function output may be initiated based on a comparison of the transducer impedance Z and one or more predetermined thresholds that have been correlated with tissue loads against the blade 146. When the transducer impedance Z transitions above or below (e.g., crosses) a threshold, the processor 400 applies a digital frequency signal 418 to the DDS circuit 420 to change the frequency of the drive signal 416 by a predetermined step in accordance with the step function algorithm(s) 402 responsive to the transducer impedance Z. In operation, the blade 146 is first located at the tissue treatment site. The processor 400 applies a first digital frequency signal 418 to set a first drive frequency f₁that is off resonance (e.g., f_o/2, 2f_oor other structural resonant frequencies, where f_ois the resonant frequency). The drive signal 416 is applied to the transducer 114 in response to activation of the switch 312a on the handpiece assembly 160 or the foot switch 434. During this period the ultrasonic transducer 114 mechanically activates the blade 146 at the first drive frequency f₁. A force or load may be applied to the clamp member 151 and the blade 146 to facilitate this process. During this period, the processor 400 monitors the transducer impedance Z until the load on the blade 146 changes and the transducer impedance Z crosses a predetermined threshold to indicate that the tissue layer has been transected. The processor 400 then applies a second digital frequency signal 418 to set a second drive frequency f₂, e.g., the resonant frequency f_oor other suitable frequency for transecting, coagulating, and sealing tissue. Another portion of the tissue (e.g., the vessel) is then grasped between the clamp member 151 and the blade 146. The transducer 114 is now energized by the drive signal 416 at the second drive frequency f₂by actuating either the foot switch 434 or the switch 312a on the handpiece assembly 160. It will be appreciated by those skilled in the art that the drive current (I) output also may be stepped as described with reference to FIGS. 6-8 based on the transducer impedance Z.

[0099] According to one embodiment of a step function algorithm 402, the processor 400 initially sets a first drive frequency f₁that is significantly off resonance to separate the inner muscle layer of the vessel from the adventitia layer. During this period of operation the processor 400 monitors the transducer impedance Z to determine when the inner muscle layer is transected or separated from the adventitia layer. Because the transducer impedance Z is correlated to the load applied to the blade 146, for example, cutting more tissue decrease the load on the blade 146 and the transducer impedance Z. The transection of the inner muscle layer is detected when the transducer impedance Z drops below a predetermined threshold. When the change in transducer impedance Z indicates that the vessel has been separated from the inner muscle layer, the processor 400 sets the drive frequency to the resonant frequency f_o. The vessel is then grasped between the blade 146 and the clamp member 151 and the transducer 114 is activated by actuating either the foot switch or the switch on the handpiece assembly 160 to transect and seal the vessel. In one embodiment, the impedance Z change may range between about 1.5 to about 4 times a base impedance measurements from an initial point of contact with the tissue to a point just before the muscle layer is transected and sealed.

[0100] With reference now to FIGS. 1, 8, and 19, as previously discussed, in one embodiment, the surgical system 100, and the ultrasonic surgical instrument 110, comprises the signal generator module 102. In one embodiment, the signal generator module 102 may be implemented as a tissue impedance module 502. Although in the presently disclosed embodiment, the signal generator module 102 is shown separate from the surgical instrument 110, in one embodiment, the signal generator module 102 may be formed integrally with the surgical instrument 110, as shown in phantom in FIG. 1, such that the surgical instrument 110 forms a unitary surgical system. In one embodiment, surgical instrument the signal generator module 102 may be configured to monitor the electrical impedance Z_tof the tissue T (FIGS. 5, 10, 16, 17) to control the characteristics of time and power level based on the impedance Z_tof the tissue T. In one embodiment, the tissue impedance Z_tmay be determined by applying a subtherapeutic radio frequency (RF) signal to the tissue T and measuring the current through the tissue T by way of a return electrode on the clamp member 151, as previously discussed. In another embodiment, the tissue impedance Z_tmay be determined by measuring a therapeutic radio frequency (RF) signal applied to the tissue T by measuring the current through the tissue T by way of a return electrode on the clamp member 151. In the schematic diagram shown in FIG. 19, an end effector portion of the surgical system 100 comprises the clamp arm assembly 451 (FIG. 8) connected to the distal end of the outer sheath 158. The blade 146 forms a first (e.g., energizing) electrode and the clamp arm assembly 451 comprises an electrically conductive portion that forms a second (e.g., return) electrode. The tissue impedance module 502 is coupled to the blade 146 and the clamp arm assembly 451 through a suitable transmission medium such as a cable 137. The cable 137 comprises multiple electrical conductors for applying a voltage to the tissue T and providing a return path for current flowing through the tissue T back to the impedance module 502. In various embodiments, the tissue impedance module 502 may be formed integrally with the generator 112 or may be provided as a separate circuit coupled to the generator 112 (shown in phantom to illustrate this option). In one embodiment, the signal generator module 102 may generate a therapeutic RF signal in response to a change in the tissue impedance Z_t.

[0101] Still with reference to FIGS. 1, 8, and 19 illustrates one embodiment of an integrated generator module 320 comprising the ultrasonic generator module 180 and the signal generator module 102. As shown, the signal generator module 102 is configured as a tissue impedance module 502. The integrated generator module 320 generates the ultrasonic electrical drive signal 416 to drive the ultrasonic transducer 114. In one embodiment, the tissue impedance module 502 may be configured to measure the impedance Z_tof the tissue T (FIGS. 5, 10, 16, 17) grasped between the blade 146 and the clamp arm assembly 451. The tissue impedance module 502 comprises an RF oscillator 506, a voltage sensing circuit 508, and a current sensing circuit 510. The voltage and current sensing circuits 508, 510 respond to the RF voltage v_rfapplied to the blade 146 electrode and the RF current i_rfflowing through the blade 146 electrode, the tissue, and the conductive portion of the clamp arm assembly 451. The sensed voltage v_rfand current i_rfare converted to digital form by the ADC 432 via the analog multiplexer 430. The processor 400 receives the digitized output 433 of the ADC 432 and determines the tissue impedance Z_tby calculating the ratio of the RF voltage v_rfto current i_rfmeasured by the voltage sense circuit 508 and the current sense circuit 510. In one embodiment, the transection of the inner muscle layer and the tissue may be detected by sensing the tissue impedance Z_t. Accordingly, detection of the tissue impedance Z_tmay be integrated with an automated process for separating the inner muscle layer from the outer adventitia layer prior to transecting the tissue without causing a significant amount of heating, which normally occurs at resonance. Additional clamp arm and sheath assemblies comprising an electrode as shown in FIGS. 9-17 may be employed without limitation.

[0102] FIG. 20 is a schematic diagram of the signal generator module 102 configured as the tissue impedance module 502 coupled to the blade 146 and the clamp arm assembly 415 with tissue T located therebetween. With reference now to FIGS. 1, 8, and 18-20, the generator 112 comprises the signal generator module 102 configured as the tissue impedance module 502 configured for monitoring the impedance Z_tof the tissue T located between the blade 146 and the clamp arm assembly 451 during the tissue transection process. The tissue impedance module 502 may is coupled to the ultrasonic surgical instrument 110 by way of the cables 137, 139. The cable includes a first “energizing” conductor 139 connected to the blade 146 (e.g., positive [+] electrode) and a second “return” conductor 137 connected to the conductive jacket 472 (e.g., negative [−] electrode) of the clamp arm assembly 451. In one embodiment, RF voltage v_rfis applied to the blade 146 to cause RF current i_rfto flow through the tissue T. The second conductor 137 provides the return path for the current i_rfback to the tissue impedance module 502. The distal end of the return conductor 137 is connected to the conductive jacket 472 such that the current i_rfcan flow from the blade 146, through the tissue T positioned intermediate the conductive jacket 472 and the blade 146, and the conductive jacket 472 to the return conductor 137. The impedance module 502 connects in circuit, by way of the first and second conductors 137, 139. In one embodiment, the RF energy may be applied to the blade 146 through the ultrasonic transducer 114 and the waveguide 147. It is worthwhile noting that the RF energy applied to the tissue T for purposes of measuring the tissue impedance Z_tis a low level subtherapeutic signal that does not contribute in a significant manner, or at all, to the treatment of the tissue T.

[0103] Having described operational details of various embodiments of the surgical system 100, operations for the above surgical system 100 may be further described with reference to FIGS. 1, 8, and 18-20 in terms of a process for cutting and coagulating a blood vessel employing a surgical instrument comprising the input device 406 and the tissue impedance module 502. Although a particular process is described in connection with the operational details, it can be appreciated that the process merely provides an example of how the general functionality described herein can be implemented by the surgical system 100. Further, the given process does not necessarily have to be executed in the order presented herein unless otherwise indicated. As previously discussed, the input device 406 may be employed to program the step function output (e.g., current, voltage, frequency) to the ultrasonic transducer 114/blade 146 assembly.

[0104] In one embodiment, the ultrasonic surgical instrument 110 may be operated in accordance with a programmed step function algorithm 402 responsive to the tissue impedance Z_t. In one embodiment, a frequency step function output may be initiated based on a comparison of the tissue impedance Z_tand predetermined thresholds that have been correlated with various tissue states (e.g., desiccation, transection, sealing). When the tissue impedance Z_ttransitions above or below (e.g., crosses) a threshold, the processor 400 applies a digital frequency signal 418 to the DDS circuit 420 to change the frequency of an ultrasonic oscillator by a predetermined step in accordance with the step function algorithm 402 responsive to the tissue impedance Z_t.

[0105] In operation, the blade 146 is located at the tissue treatment site. The tissue T is grasped between the blade 146 and the clamp arm assembly 451 such that the blade 146 and the conductive jacket 472 make electrical contact with the tissue T. The processor 400 applies a first digital frequency signal 418 to set a first drive frequency f₁that is off resonance (e.g., f_o/2, 2f_oor other structural resonant frequencies, where f_ois the resonant frequency). The blade 146 is electrically energized by the low level subtherapeutic RF voltage v_rfsupplied by the tissue impedance module 502. The drive signal 416 is applied to the transducer 114/blade 146 in response to actuation of the switch 143 on the handpiece assembly 160 or the foot switch 144434 until the tissue impedance Z_tof the tissue T changes by a predetermined amount. A force or load is then applied to the clamp arm assembly 451 and the blade 146. During this period the ultrasonic transducer 114 mechanically activates the blade 146 at the first drive frequency f₁and as a result, the tissue T begins to desiccate from the ultrasonic action applied between the blade 146 and the one or more clamp pads 155 of the clamp arm assembly 451 causing the impedance Z_tof the tissue T to increase. Eventually, as the tissue T is transected by the ultrasonic action and applied clamp force, the impedance Z_tof the tissue T becomes very high or infinite. It will be appreciated by those skilled in the art that the drive current (I) output also may be stepped as described above based on measured impedance Z_tof the tissue T.

[0106] In one embodiment, the impedance Z_tof tissue T may be monitored by the impedance module 502 in accordance with the following process. A measurable RF current i₁is conveyed through the first energizing conductor 139 to the blade 146, through the tissue T, and back to the impedance module 502 through the conductive jacket 472 and the second conductor 137. As the tissue T is desiccated and cut by the ultrasonic action of the blade 146 acting against the one or more clamp pads 155, the impedance of the tissue 514 increases and thus the current i₁in the return path, i.e., the second conductor 137, decreases. The impedance module 502 measures the tissue impedance Z_tand conveys a representative signal to the ADC 432 whose digital output 433 is provided to the processor 400. The processor 400 calculates the tissue impedance Z_tbased on these measured values of v_rfand i_rf. In response to the transducer impedance (Z_t), the processor 400 controls the operation of the surgical instrument 110. For example, the processor 400 can adjust the power delivered to the transducer 114, can shut off the power to the transducer 114, and/or provide feedback to the user. In one embodiment, the processor 400 steps the frequency by any suitable increment or decrement in response to changes in the impedance Z_tof the tissue T. In other embodiments, the processor 400 controls the drive signals 416 and can make any necessary adjustments in amplitude and frequency in response to the tissue impedance Z_tIn one embodiment, the processor 400 can cut off the drive signal 416 when the tissue impedance Z_treaches a predetermined threshold value.

[0107] Accordingly, by way of example, and not limitation, in one embodiment, the ultrasonic surgical instrument 110 may be operated in accordance with a programmed stepped output algorithm to separate the inner muscle layer of a vessel from the adventitia layer prior to transecting and sealing the vessel. As previously discussed, according to one step function algorithm, the processor 400 initially sets a first drive frequency f_tthat is significantly off resonance. The transducer 114 is activated to separate the inner muscle layer of the vessel from the adventitia layer and the tissue impedance module 502 applies a subtherapeutic RF voltage v_rfsignal to the blade 146. During this period T₁of operation the processor 400 monitors the tissue impedance Z_tto determine when the inner muscle layer is transected or separated from the adventitia layer. The tissue impedance Z_tis correlated to the load applied to the blade 146, for example, when the tissue becomes desiccated or when the tissue is transected the tissue impedance Z_tbecomes extremely high or infinite. The change in tissue impedance Z_tindicates that the vessel has been separated or transected from the inner muscle layer and the generator 112 is deactivated for a second period of time T₂. The processor 400 then sets the drive frequency to the resonant frequency f_o. The vessel is then grasped between the blade 146 and the clamp arm assembly 451 and the transducer 114 is reactivated to transect and seal the vessel. Continuous monitoring of the tissue impedance Z_tprovides an indication of when the vessel is transected and sealed. Also, the tissue impedance Z_tmay be monitored to provide an indication of the completeness of the tissue cutting and/or coagulating process or to stop the activation of the generator 112 and/or the ultrasonic generator module 180 when the impedance Z_tof the tissue T reaches a predetermined threshold value. The threshold for the tissue impedance Z_tmay be selected, for example, to indicate that the vessel has been transected. In one embodiment, the tissue impedance Z_tmay range between about 10 Ohms to about 1000 Ohms from an initial point to a point just before the muscle layer is transected and sealed.

[0108] The applicants have discovered that experiments that run varying current set points (both increasing and decreasing) and dwell times indicate that the described embodiments can be used to separate the inner muscle layer from the outer adventitia layer prior to completing the transection resulting in improved hemostasis and potentially lower total energy (heat) at the transection site. Furthermore, although the surgical instrument 110 has been described in regards to impedance threshold detection schemes to determine when the muscle layer is separated from the adventitia, other embodiments that do not employ any detection scheme are within the scope of the present disclosure. For example, embodiments of the surgical instrument 110 may be employed in simplified surgical systems wherein non-resonant power is applied to separate the layers for a predetermined time of approximately 1 second or less, prior to applying a resonant power to cut the tissue. The embodiments are not limited in this context.

[0109] In one embodiment, the surgical instrument may be operated to produce a therapeutic RF signal in response to the monitored impedance Z_tof tissue T. In this embodiment, the processor 400 may initially set a first drive frequency f_tfor operating the transducer. The tissue impedance module 502 may be operated to apply a subtherapeutic RF voltage v_rfsignal to the blade 146. During this period T₁f operation the processor 400 monitors the tissue impedance Z_tto determine when a successful ultrasonic operation has been completed. The ultrasonic operations may include, for example separation of the inner muscle layer from the adventitia layer or coagulation of a vessel. The change in tissue impedance Z_tindicates the completion of the ultrasonic operation and the generator 112 may be deactivated for a second time period T₂. The processor 400 may then set the signal generator module 102 to produce a therapeutic RF signal. The processor 400 may operate the signal generator module 102 to deliver the therapeutic RF signal through cables 137, 139. The cables may include a first “energizing” conductor 139 connected to the blade 146 (e.g., positive [+] electrode) and a second “return” conductor 137 connected to the conductive jacket 472 (e.g., negative [−] electrode) of the clamp arm assembly 451. The processor 400 may continuously monitor the tissue impedance Z_tto provide an indication of a completed electrosurgical treatment, such as, for example, tissue desiccation. When the tissue impedance Z_treaches a predetermined threshold value, the generator 112 may be deactivated. The threshold for the tissue impedance Z_tmay be selected, for example, to indicate that the tissue T has been desiccated.

[0110] In various embodiments, the surgical instrument 110 may be programmed for detecting a change of state of tissue being manipulated by an ultrasonic surgical instrument and providing feedback to the user to indicate that the tissue has undergone such change of state or that there is a high likelihood that the tissue has undergone such change of state. As used herein, the tissue may undergo a change of state when the tissue is separated from other layers of tissue or bone, when the tissue is cut or transected, when the tissue is coagulated, and so forth while being manipulated with an end effector of an ultrasonic surgical instrument, such as, for example, the end effector 150 of the ultrasonic surgical instrument 110. A change in tissue state may be determined based on the likelihood of an occurrence of a tissue separation event.

[0111] With reference to FIGS. 1, 5, and 18-20, in various embodiments, the impedance Z and the tissue Z_t, as well as any other suitable electrical measurements, that can be made with the surgical system 100, may be used to provide feedback by the output indicator 412 shown in FIGS. 18 and 19. The output indicator 412 is particularly useful in applications where the tissue being manipulated by the end effector 151 is out of the user's field of view and the user cannot see when a change of state occurs in the tissue T. The output indicator 412 communicates to the user that a change in tissue state has occurred as determined in accordance with the operations described with respect to various logic flows. As previously discussed, the output indicator 412 may be configured to provide various types of feedback to the user including, without limitation, visual, audible, and/or tactile feedback to indicate to the user (e.g., surgeon, clinician) that the tissue has undergone a change of state of the tissue. By way of example, and not limitation, as previously discussed, visual feedback comprises any type of visual indication device including incandescent lamps or LEDs, graphical user interface, display, analog indicator, digital indicator, bar graph display, digital alphanumeric display. By way of example, and not limitation, audible feedback comprises any type of buzzer, computer generated tone, computerized speech, VUI to interact with computers through a voice/speech platform. By way of example, and not limitation, tactile feedback comprises any type of vibratory feedback provided through the instrument housing handpiece assembly 160.

[0112] The processor 400 to determines a change in tissue state in accordance with the operations described above and provides feedback to the user by way of the output indicator 412. The processor 400 monitors and evaluates the voltage, current, and/or frequency signal samples available from the generator 32, 320 and according to the evaluation of such signal samples determines whether a change in tissue state has occurred. A change in tissue state may be determined based on the type of ultrasonic instrument and the power level that the instrument is energized at. In response to the feedback, the operational mode of the ultrasonic surgical instrument 110 may be controlled by the user or may be automatically or semi-automatically controlled.

[0113] In one embodiment, the processor 400 portion of the drive system 32, 320 samples the voltage (v), current (i), and frequency (f) signals of the ultrasonic generator module 180 and/or the signal generator module 102. As previously discussed, the output indicator 412 may provide visual, audible, and/or tactile feedback to alert the user of the ultrasonic surgical instrument 110 that a change in tissue state has occurred. In various embodiments, in response to the feedback from the output indicator 412, the operational modes of the generator 112, the ultrasonic generator module 180, the signal generator module 102, and/or the ultrasonic instrument 110 may be controlled manually, automatically, or semi-automatically. The operational modes include, without limitation, disconnecting or shutting down the output power, reducing the output power, cycling the output power, pulsing the output power, and/or outputting momentary surge of high-power. In one embodiment, the operational modes include, operating the surgical instrument 110 in a first operating mode in which the transducer 14 produces mechanical energy, or vibrations, that are transmitted to the end effector 151 and a second operating mode in which electrical energy, or current, can flow through the end effector 151 to perform electrosurgery. The operational modes of the ultrasonic instrument 110 in response to the change in tissue state can be selected, for example, to minimize heating effects of the end effector 151, e.g., of the clamp pad 155, to prevent or minimize possible damage to the surgical instrument 110, and/or surrounding tissue. This is advantageous because heat is generated exponentially when the transducer 114 is activated with nothing between the jaws of the end effector 151 as is the case when a change in tissue state occurs.

[0114] In various embodiments, the change of state of the tissue may be determined based on transducer and tissue impedance measurements as previously described, or based on voltage, current, and frequency measurements in accordance with the operations described in the disclosure of the following commonly-owned, contemporaneously-filed U.S. patent application, which is incorporated herein by reference in its entirety: U.S. patent application Ser. No. 12/503,775, entitled “ULTRASONIC DEVICE FOR CUTTING AND COAGULATING WITH STEPPED OUTPUT,” now U.S. Pat. No. 8,058,771.

[0115] The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.

[0116] Preferably, the various embodiments described herein will be processed before surgery. First, a new or used instrument is obtained and if necessary cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility. Sterilization can also be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, and/or steam.

[0117] In various embodiments, an ultrasonic surgical instrument can be supplied to a surgeon with a waveguide and/or end effector already operably coupled with a transducer of the surgical instrument. In at least one such embodiment, the surgeon, or other clinician, can remove the ultrasonic surgical instrument from a sterilized package, plug the ultrasonic instrument into a generator, as outlined above, and use the ultrasonic instrument during a surgical procedure. Such a system can obviate the need for a surgeon, or other clinician, to assemble a waveguide and/or end effector to the ultrasonic surgical instrument. After the ultrasonic surgical instrument has been used, the surgeon, or other clinician, can place the ultrasonic instrument into a sealable package, wherein the package can be transported to a sterilization facility. At the sterilization facility, the ultrasonic instrument can be disinfected, wherein any expended parts can be discarded and replaced while any reusable parts can be sterilized and used once again. Thereafter, the ultrasonic instrument can be reassembled, tested, placed into a sterile package, and/or sterilized after being placed into a package. Once sterilized, the reprocessed ultrasonic surgical instrument can be used once again.

[0118] Although various embodiments have been described herein, many modifications and variations to those embodiments may be implemented. For example, different types of end effectors may be employed. Also, where materials are disclosed for certain components, other materials may be used. The foregoing description and following claims are intended to cover all such modification and variations.

[0119] Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.

Claims

What is claimed is:

1. A method of controlling a surgical instrument, the method comprising:

generating a first ultrasonic drive signal by an ultrasonic generator coupled to an ultrasonic drive system, wherein the first ultrasonic drive signal has a first frequency f₁, wherein the ultrasonic drive system comprises an ultrasonic transducer coupled to a waveguide and an end effector coupled to the waveguide, and wherein the ultrasonic drive system is configured to resonate mechanically at a resonant frequency;

operating the ultrasonic transducer at the first ultrasonic drive signal for a first period;

monitoring an electrical characteristic;

controlling the ultrasonic generator in response to the monitored electrical characteristic, wherein the ultrasonic generator is controlled based on a predetermined function responsive to the monitored electrical characteristic, wherein the predetermined function comprises a step function, wherein the first ultrasonic drive signal operates the end effector to separate a muscle layer from a tissue section;

generating a second ultrasonic drive signal by the ultrasonic generator, wherein the second ultrasonic drive signal has a second frequency f₀, wherein the first frequency f₁and the second frequency f₀are different, and wherein the second ultrasonic drive signal operates the end effector to cut and seal the tissue section; and

operating the ultrasonic transducer at the second drive signal for a second period, wherein the first period and the second period are continuous, and wherein the first period and the second period are determined by the predetermined function.

2. The method of claim 1, wherein the monitored electrical characteristic is impedance of the ultrasonic transducer.

3. The method of claim 1, wherein the monitored electrical characteristic is impedance of a tissue portion contacting the end effector.

4. The method of claim 1, comprising:

generating a therapeutic electrical signal by an electrosurgical generator coupled to the end effector in response to the monitored electrical characteristic.

5. The method of claim 1, comprising:

providing feedback in response to the monitored electrical characteristic.

6. The method of claim 1, comprising:

generating a subtherapeutic electrical signal by a signal generator coupled to the end effector;

applying the subtherapeutic electrical signal to a tissue portion contacting the end effector; and

monitoring an electrical characteristic of the tissue portion.

7. The method of claim 6, comprising:

controlling one of the first and second ultrasonic drive signals in response to the monitored electrical characteristic of the tissue portion.

8. The method of claim 7, comprising:

generating a therapeutic electrical signal by an electrosurgical generator coupled to the end effector in response to the monitored electrical characteristic of the tissue portion.

9. The method of claim 6, comprising:

providing feedback in response to the monitored electrical characteristic of the tissue portion.

10. The method of claim 1, wherein the first frequency is an off resonance frequency f₁, and wherein the second frequency is a resonance frequency f₀.

11. The method of claim 10, wherein the off resonance frequency f₁is defined as a frequency of 2*f₀.

12. The method of claim 1, wherein the off resonance signal f₁is defined as a frequency of f₀/2.

13. The method of claim 1, wherein the monitored electrical characteristic comprises an electrical characteristic of the ultrasonic generator.

14. A surgical instrument, comprising:

an ultrasonic generator coupled to an ultrasonic drive system, wherein the ultrasonic drive system comprises an ultrasonic transducer coupled to a waveguide and an end effector coupled to the waveguide, and wherein the ultrasonic drive system is configured to resonate mechanically at a resonant frequency, wherein the ultrasonic generator is to generate a first ultrasonic drive signal having a first frequency and a second ultrasonic drive signal having a second frequency, wherein the first and second frequencies are different;

an electronic circuit coupled to the ultrasonic generator module, wherein the electronic circuit is to monitor an electrical characteristic; and

a processor coupled to the electronic circuit, wherein the processor is to control one of the first and second ultrasonic drive signals in response to the monitored electrical characteristic, wherein the processor operates the ultrasonic transducer at the first ultrasonic drive signal for a first period, wherein the first period ends at a predetermined electrical characteristic, wherein the processor operates the ultrasonic transducer at the second ultrasonic drive signal for a second period, wherein the first period and the second period are continuous, wherein the first period and the second period are determined by a predetermined function responsive to the predetermined electrical characteristic, wherein the predetermined function comprises a step function, wherein the first ultrasonic drive signal operates the end effector to separate a muscle layer from a tissue section, and wherein the second ultrasonic drive signal operates the end effector to cut and seal the tissue section.

15. The surgical instrument apparatus of claim 14, wherein the electronic circuit comprises:

a current sense circuit to sense electrical current flowing through the transducer; and

a voltage sense circuit to sense output voltage applied to the transducer.

16. The surgical instrument of claim 14, comprising:

an electrosurgical generator coupled to the end effector, wherein the electrosurgical generator is to generate a therapeutic electrical signal in response to the monitored electrical characteristic.

17. The surgical instrument of claim 14, comprising:

an output indicator coupled to the processor to provide feedback in response to the monitored electrical characteristic.

18. The surgical instrument of claim 14, comprising:

a signal generator coupled to the end effector to generate a subtherapeutic electrical signal;

an electrode coupled to the end effector and to the signal generator, wherein the electrode is to apply the subtherapeutic electrical signal to a tissue portion contacting the end effector;

a current sense circuit coupled to the signal generator to sense electrical signal flowing through the tissue portion; and

a voltage sense circuit coupled to the signal generator to sense the voltage applied to the tissue portion.

19. A surgical system, the system comprising:

an ultrasonic generator coupled to an ultrasonic drive system, wherein the ultrasonic drive system comprises an ultrasonic transducer coupled to a waveguide and an end effector coupled to the waveguide, wherein the ultrasonic drive system is configured to resonate mechanically at a resonant frequency, wherein the ultrasonic generator is to generate a first ultrasonic drive signal having a first frequency and a second ultrasonic drive signal having a second frequency, wherein the first and second frequencies are different;

an electrosurgical generator coupled to the end effector to generate a therapeutic electrical signal;

a signal generator coupled to the end effector to generate a subtherapeutic electrical signal; and

a processor coupled to the ultrasonic generator and the signal generator, wherein the processor monitors an electrical characteristic of the ultrasonic drive system, wherein the processor operates the ultrasonic transducer at the first ultrasonic drive signal for a first period, wherein the first period ends at a predetermined electrical characteristic, wherein the processor operates the ultrasonic transducer at the second ultrasonic drive signal for a second period, wherein the first period and the second period are continuous, and wherein the first period and the second period are determined by a predetermined function responsive to the predetermined electrical characteristic, wherein the predetermined function comprises a step function, wherein the first drive signal operates the end effector to separate a muscle layer from a tissue section, and wherein the second drive signal operates the end effector to cut and seal the tissue section.

20. The system of claim 19, comprising:

an electronic circuit coupled to the ultrasonic generator module, wherein the electronic circuit is to monitor the electrical characteristic of the ultrasonic drive system, wherein the electronic circuit comprises:

a current sense circuit to sense electrical current flowing through the ultrasonic transducer; and

a voltage sense circuit to sense output voltage applied to the ultrasonic transducer.

21. The system of claim 19, wherein the electrosurgical generator is to generate a therapeutic electrical signal in response to the monitored electrical characteristic of the ultrasonic drive system.

22. The system of claim 19, comprising:

an output indicator coupled to the processor to provide feedback in response to the monitored electrical characteristic of the ultrasonic drive system.

23. The system of claim 19, comprising:

an electrode coupled to the end effector and to the signal generator, wherein the electrode is to apply the subtherapeutic electrical signal to a tissue portion contacting the end effector;

a current sense circuit coupled to the signal generator to sense electrical signal flowing through the tissue portion; and

a voltage sense circuit coupled to the signal generator to sense voltage applied to the tissue portion.

24. A method of controlling a surgical instrument, the method comprising:

generating a first ultrasonic drive signal by an ultrasonic generator coupled to an ultrasonic drive system, wherein the first ultrasonic drive signal has a first frequency, wherein the ultrasonic drive system comprises an ultrasonic transducer coupled to a waveguide and an end effector coupled to the waveguide, wherein the ultrasonic drive system is configured to resonate mechanically at a resonant frequency, and wherein the first frequency is an off resonance frequency f₁;

operating the ultrasonic transducer at the first ultrasonic drive signal for a first period;

monitoring an electrical characteristic;

generating a second ultrasonic drive signal by the ultrasonic generator, wherein the second ultrasonic drive signal has a second frequency, and wherein the second frequency is a resonance frequency f₀;

operating the ultrasonic transducer at the second ultrasonic drive signal for a second period, wherein the first period and the second period are continuous, and wherein the first period and the second period are determined by the predetermined function, and

wherein the off resonance frequency f₁is defined as a half-integer multiple of the resonant frequency f₀.

Patent Citations (734)

Patent	Date	Inventor	Cited By
US969528(A)	1910-09-01	Disbrow	Applicant
US1570025(A)	1926-01-01	Young	Applicant
US2704333(A)	1955-03-01	Calosi et al.	Applicant
US2736960(A)	1956-03-01	Armstrong	Applicant
US2849788(A)	1958-09-01	Creek	Applicant
USRE25033(E)	1961-08-01	Balamuth et al.	Applicant
US3015961(A)	1962-01-01	Roney	Applicant
US3513848(A)	1970-05-01	Winston et al.	Applicant
US3526219(A)	1970-09-01	Balamuth	Applicant
US3614484(A)	1971-10-01	Shoh	Applicant
US3636943(A)	1972-01-01	Balamuth	Applicant
US3776238(A)	1973-12-01	Peyman et al.	Applicant
US3805787(A)	1974-04-01	Banko	Applicant
US3830098(A)	1974-08-01	Antonevich	Applicant
US3854737(A)	1974-12-01	Gilliam, Sr.	Applicant
US3862630(A)	1975-01-01	Balamuth	Applicant
US3900823(A)	1975-08-01	Sokal et al.	Applicant
US3918442(A)	1975-11-01	Nikolaev et al.	Applicant
US3946738(A)	1976-03-01	Newton et al.	Applicant
US3955859(A)	1976-05-01	Stella et al.	Applicant
US3956826(A)	1976-05-01	Perdreaux, Jr.	Applicant
US4156187(A)	1979-05-01	Murry et al.	Applicant
US4188927(A)	1980-02-01	Harris	Applicant
US4200106(A)	1980-04-01	Douvas et al.	Applicant
US4306570(A)	1981-12-01	Matthews	Applicant
US4445063(A)	1984-04-01	Smith	Applicant
US4491132(A)	1985-01-01	Aikins	Applicant
US4504264(A)	1985-03-01	Kelman	Applicant
US4574615(A)	1986-03-01	Bower et al.	Applicant
US4617927(A)	1986-10-01	Manes	Applicant
US4633119(A)	1986-12-01	Thompson	Applicant
US4634420(A)	1987-01-01	Spinosa et al.	Applicant
US4640279(A)	1987-02-01	Beard	Applicant
US4649919(A)	1987-03-01	Thimsen et al.	Applicant
US4708127(A)	1987-11-01	Abdelghani	Applicant
US4712722(A)	1987-12-01	Hood et al.	Applicant
US4827911(A)	1989-05-01	Broadwin et al.	Applicant
US4832683(A)	1989-05-01	Idemoto et al.	Applicant
US4838853(A)	1989-06-01	Parisi	Applicant
US4850354(A)	1989-07-01	McGurk-Burleson et al.	Applicant
US4865159(A)	1989-09-01	Jamison	Applicant
US4896009(A)	1990-01-01	Pawlowski	Applicant
US4903696(A)	1990-02-01	Stasz et al.	Applicant
US4922902(A)	1990-05-01	Wuchinich et al.	Applicant
US4965532(A)	1990-10-01	Sakurai	Applicant
US4979952(A)	1990-12-01	Kubota et al.	Examiner
US4981756(A)	1991-01-01	Rhandhawa	Applicant
US5026387(A)	1991-06-01	Thomas	Applicant
US5109819(A)	1992-05-01	Custer et al.	Applicant
US5112300(A)	1992-05-01	Ureche	Applicant
US5123903(A)	1992-06-01	Quaid et al.	Applicant
US5126618(A)	1992-06-01	Takahashi et al.	Applicant
US5162044(A)	1992-11-01	Gahn et al.	Applicant
US5163537(A)	1992-11-01	Radev	Applicant
US5167725(A)	1992-12-01	Clark et al.	Applicant
USD332660(S)	1993-01-01	Rawson et al.	Applicant
US5176677(A)	1993-01-01	Wuchinich	Applicant
US5176695(A)	1993-01-01	Dulebohn	Applicant
US5184605(A)	1993-02-01	Grzeszykowski	Applicant
US5188102(A)	1993-02-01	Idemoto et al.	Applicant
US5213569(A)	1993-05-01	Davis	Applicant
US5221282(A)	1993-06-01	Wuchinich	Applicant
US5226909(A)	1993-07-01	Evans et al.	Applicant
US5226910(A)	1993-07-01	Kajiyama et al.	Applicant
US5241236(A)	1993-08-01	Sasaki et al.	Applicant
US5257988(A)	1993-11-01	L'Esperance, Jr.	Applicant
US5261922(A)	1993-11-01	Hood	Applicant
US5263957(A)	1993-11-01	Davison	Applicant
US5275609(A)	1994-01-01	Pingleton et al.	Applicant
US5282800(A)	1994-02-01	Foshee et al.	Applicant
US5304115(A)	1994-04-01	Pflueger et al.	Applicant
USD347474(S)	1994-05-01	Olson	Applicant
US5322055(A)	1994-06-01	Davison et al.	Applicant
US5324299(A)	1994-06-01	Davison et al.	Applicant
US5326342(A)	1994-07-01	Pflueger et al.	Applicant
US5344420(A)	1994-09-01	Hilal et al.	Applicant
US5346502(A)	1994-09-01	Estabrook et al.	Applicant
US5353474(A)	1994-10-01	Good et al.	Applicant
US5357164(A)	1994-10-01	Imabayashi et al.	Applicant
US5357423(A)	1994-10-01	Weaver et al.	Examiner
US5366466(A)	1994-11-01	Christian et al.	Applicant
US5371429(A)	1994-12-01	Manna	Applicant
USD354564(S)	1995-01-01	Medema	Applicant
US5381067(A)	1995-01-01	Greenstein et al.	Applicant
US5403312(A)	1995-04-01	Yates et al.	Applicant
USD358887(S)	1995-05-01	Feinberg	Applicant
US5411481(A)	1995-05-01	Allen et al.	Applicant
US5419761(A)	1995-05-01	Narayanan et al.	Applicant
US5421829(A)	1995-06-01	Olichney et al.	Applicant
US5438997(A)	1995-08-01	Sieben et al.	Applicant
US5449370(A)	1995-09-01	Vaitekunas	Examiner
US5471988(A)	1995-12-01	Fujio et al.	Applicant
US5483501(A)	1996-01-01	Park et al.	Applicant
US5486162(A)	1996-01-01	Brumbach	Applicant
US5500216(A)	1996-03-01	Julian et al.	Applicant
US5501654(A)	1996-03-01	Failla et al.	Applicant
US5505693(A)	1996-04-01	Mackool	Applicant
US5507738(A)	1996-04-01	Ciervo	Applicant
US5527331(A)	1996-06-01	Kresch et al.	Applicant
US5562609(A)	1996-10-01	Brumbach	Applicant
US5562610(A)	1996-10-01	Brumbach	Applicant
US5577654(A)	1996-11-01	Bishop	Applicant
US5601601(A)	1997-02-01	Tal et al.	Applicant
US5603773(A)	1997-02-01	Campbell	Applicant
US5607436(A)	1997-03-01	Pratt et al.	Applicant
US5618492(A)	1997-04-01	Auten et al.	Applicant
US5628760(A)	1997-05-01	Knoepfler	Applicant
US5630420(A)	1997-05-01	Vaitekunas	Examiner
USD381077(S)	1997-07-01	Hunt	Applicant
US5651780(A)	1997-07-01	Jackson et al.	Applicant
US5653713(A)	1997-08-01	Michelson	Applicant
US5669922(A)	1997-09-01	Hood	Applicant
US5674235(A)	1997-10-01	Parisi	Applicant
US5690269(A)	1997-11-01	Bolanos et al.	Applicant
US5694936(A)	1997-12-01	Fujimoto et al.	Applicant
US5713896(A)	1998-02-01	Nardella	Applicant
US5730752(A)	1998-03-01	Alden et al.	Applicant
US5733074(A)	1998-03-01	Stöck et al.	Applicant
US5741226(A)	1998-04-01	Strukel et al.	Applicant
US5792135(A)	1998-08-01	Madhani et al.	Applicant
US5792165(A)	1998-08-01	Klieman et al.	Applicant
US5808396(A)	1998-09-01	Boukhny	Applicant
US5810859(A)	1998-09-01	DiMatteo et al.	Applicant
US5817084(A)	1998-10-01	Jensen	Applicant
US5817119(A)	1998-10-01	Klieman et al.	Applicant
US5827323(A)	1998-10-01	Klieman et al.	Applicant
US5828160(A)	1998-10-01	Sugishita	Applicant
US5833696(A)	1998-11-01	Whitfield et al.	Applicant
US5836897(A)	1998-11-01	Sakurai et al.	Examiner
US5843109(A)	1998-12-01	Mehta et al.	Applicant
US5878193(A)	1999-03-01	Wang et al.	Applicant
US5879364(A)	1999-03-01	Bromfield et al.	Applicant
US5883615(A)	1999-03-01	Fago et al.	Applicant
US5893835(A)	1999-04-01	Witt et al.	Applicant
US5897523(A)	1999-04-01	Wright et al.	Applicant
US5897569(A)	1999-04-01	Kellogg et al.	Applicant
US5906628(A)	1999-05-01	Miyawaki et al.	Applicant
US5911699(A)	1999-06-01	Anis et al.	Applicant
US5935143(A)	1999-08-01	Hood	Applicant
US5935144(A)	1999-08-01	Estabrook	Applicant
US5938633(A)	1999-08-01	Beaupre	Applicant
US5944718(A)	1999-08-01	Austin et al.	Applicant
US5944737(A)	1999-08-01	Tsonton et al.	Applicant
US5954736(A)	1999-09-01	Bishop et al.	Applicant
US5954746(A)	1999-09-01	Holthaus et al.	Applicant
US5957882(A)	1999-09-01	Nita et al.	Applicant
US5957943(A)	1999-09-01	Vaitekunas	Applicant
US5968007(A)	1999-10-01	Simon et al.	Applicant
US5968060(A)	1999-10-01	Kellogg	Applicant
USD416089(S)	1999-11-01	Barton et al.	Applicant
US5980510(A)	1999-11-01	Tsonton et al.	Applicant
US5989274(A)	1999-11-01	Davison et al.	Applicant
US5989275(A)	1999-11-01	Estabrook et al.	Applicant
US5993972(A)	1999-11-01	Reich et al.	Applicant
US6024741(A)	2000-02-01	Williamson, IV et al.	Applicant
US6027515(A)	2000-02-01	Cimino	Applicant
US6033375(A)	2000-03-01	Brumbach	Applicant
US6050943(A)	2000-04-01	Slayton et al.	Applicant
US6051010(A)	2000-04-01	DiMatteo et al.	Applicant
US6056735(A)	2000-05-01	Okada et al.	Applicant
US6063098(A)	2000-05-01	Houser et al.	Applicant
US6066132(A)	2000-05-01	Chen et al.	Applicant
US6066151(A)	2000-05-01	Miyawaki et al.	Applicant
US6068647(A)	2000-05-01	Witt et al.	Applicant
US6077285(A)	2000-06-01	Boukhny	Applicant
US6083191(A)	2000-07-01	Rose	Applicant
US6086584(A)	2000-07-01	Miller	Applicant
US6090120(A)	2000-07-01	Wright et al.	Applicant
US6109500(A)	2000-08-01	Alli et al.	Applicant
US6110127(A)	2000-08-01	Suzuki	Applicant
US6113594(A)	2000-09-01	Savage	Applicant
US6117152(A)	2000-09-01	Huitema	Applicant
US6126629(A)	2000-10-01	Perkins	Applicant
US6129735(A)	2000-10-01	Okada et al.	Applicant
US6132368(A)	2000-10-01	Cooper	Applicant
US6139320(A)	2000-10-01	Hahn	Applicant
US6139561(A)	2000-10-01	Shibata et al.	Applicant
US6142615(A)	2000-11-01	Qiu et al.	Applicant
US6147560(A)	2000-11-01	Erhage et al.	Applicant
US6152902(A)	2000-11-01	Christian et al.	Applicant
US6159160(A)	2000-12-01	Hsei et al.	Applicant
US6159175(A)	2000-12-01	Strukel et al.	Applicant
US6165150(A)	2000-12-01	Banko	Applicant
US6204592(B1)	2001-03-01	Hur	Applicant
US6206844(B1)	2001-03-01	Reichel et al.	Applicant
US6210403(B1)	2001-04-01	Klicek	Applicant
US6214023(B1)	2001-04-01	Whipple et al.	Applicant
US6231565(B1)	2001-05-01	Tovey et al.	Applicant
US6233476(B1)	2001-05-01	Strommer et al.	Applicant
US6238366(B1)	2001-05-01	Savage et al.	Applicant
US6252110(B1)	2001-06-01	Uemura et al.	Applicant
USD444365(S)	2001-07-01	Bass et al.	Applicant
US6254623(B1)	2001-07-01	Haibel, Jr. et al.	Applicant
US6258034(B1)	2001-07-01	Hanafy	Applicant
US6267761(B1)	2001-07-01	Ryan	Applicant
US6270831(B2)	2001-08-01	Kumar et al.	Applicant
US6273852(B1)	2001-08-01	Lehe et al.	Applicant
US6274963(B1)	2001-08-01	Estabrook et al.	Applicant
US6277115(B1)	2001-08-01	Saadat	Applicant
US6278218(B1)	2001-08-01	Madan et al.	Applicant
US6283981(B1)	2001-09-01	Beaupre	Applicant
US6309400(B2)	2001-10-01	Beaupre	Applicant
US6319221(B1)	2001-11-01	Savage et al.	Applicant
US6325811(B1)	2001-12-01	Messerly	Applicant
US6328751(B1)	2001-12-01	Beaupre	Applicant
US6340352(B1)	2002-01-01	Okada et al.	Examiner
US6352532(B1)	2002-03-01	Kramer et al.	Applicant
US6364888(B1)	2002-04-01	Niemeyer et al.	Applicant
US6379320(B1)	2002-04-01	Lafon et al.	Applicant
USD457958(S)	2002-05-01	Dycus et al.	Applicant
US6383194(B1)	2002-05-01	Pothula	Applicant
US6387109(B1)	2002-05-01	Davison et al.	Applicant
US6388657(B1)	2002-05-01	Natoli	Applicant
US6391042(B1)	2002-05-01	Cimino	Applicant
US6405733(B1)	2002-06-01	Fogarty et al.	Applicant
US6416486(B1)	2002-07-01	Wampler	Applicant
US6423073(B2)	2002-07-01	Bowman	Applicant
US6423082(B1)	2002-07-01	Houser et al.	Applicant
US6428539(B1)	2002-08-01	Baxter et al.	Applicant
US6432118(B1)	2002-08-01	Messerly	Applicant
US6436114(B1)	2002-08-01	Novak et al.	Applicant
US6436115(B1)	2002-08-01	Beaupre	Applicant
US6443969(B1)	2002-09-01	Novak et al.	Applicant
US6454781(B1)	2002-09-01	Witt et al.	Examiner
US6454782(B1)	2002-09-01	Schwemberger	Applicant
US6458142(B1)	2002-10-01	Faller et al.	Applicant
US6480796(B2)	2002-11-01	Wiener	Applicant
US6485490(B2)	2002-11-01	Wampler et al.	Applicant
US6491708(B2)	2002-12-01	Madan et al.	Applicant
US6497715(B2)	2002-12-01	Satou	Applicant
US6500176(B1)	2002-12-01	Truckai et al.	Applicant
US6500188(B2)	2002-12-01	Harper et al.	Applicant
US6524251(B2)	2003-02-01	Rabiner et al.	Applicant
US6524316(B1)	2003-02-01	Nicholson et al.	Applicant
US6527736(B1)	2003-03-01	Attinger et al.	Applicant
US6533784(B2)	2003-03-01	Truckai et al.	Applicant
US6537291(B2)	2003-03-01	Friedman et al.	Applicant
US6543452(B1)	2003-04-01	Lavigne	Applicant
US6543456(B1)	2003-04-01	Freeman	Applicant
US6544260(B1)	2003-04-01	Markel et al.	Applicant
US6561983(B2)	2003-05-01	Cronin et al.	Applicant
US6572632(B2)	2003-06-01	Zisterer et al.	Applicant
US6575969(B1)	2003-06-01	Rittman, III et al.	Applicant
US6582451(B1)	2003-06-01	Marucci et al.	Applicant
US6589200(B1)	2003-07-01	Schwemberger et al.	Applicant
US6589239(B2)	2003-07-01	Khandkar et al.	Applicant
US6610059(B1)	2003-08-01	West, Jr.	Applicant
US6616450(B2)	2003-09-01	Mossle et al.	Applicant
US6623501(B2)	2003-09-01	Heller et al.	Applicant
US6626926(B2)	2003-09-01	Friedman et al.	Applicant
US6633234(B2)	2003-10-01	Wiener et al.	Applicant
US6656177(B2)	2003-12-01	Truckai et al.	Applicant
US6662127(B2)	2003-12-01	Wiener et al.	Applicant
US6663941(B2)	2003-12-01	Brown et al.	Applicant
US6669690(B1)	2003-12-01	Okada et al.	Examiner
US6676660(B2)	2004-01-01	Wampler et al.	Applicant
US6678621(B2)	2004-01-01	Wiener et al.	Applicant
US6679875(B2)	2004-01-01	Honda et al.	Applicant
US6679899(B2)	2004-01-01	Wiener et al.	Applicant
US6682544(B2)	2004-01-01	Mastri et al.	Applicant
US6689146(B1)	2004-02-01	Himes	Applicant
US6716215(B1)	2004-04-01	David et al.	Applicant
US6731047(B2)	2004-05-01	Kauf et al.	Applicant
US6733506(B1)	2004-05-01	McDevitt et al.	Applicant
US6762535(B2)	2004-07-01	Take et al.	Applicant
US6770072(B1)	2004-08-01	Truckai et al.	Applicant
US6773443(B2)	2004-08-01	Truwit et al.	Applicant
US6773444(B2)	2004-08-01	Messerly	Applicant
US6783524(B2)	2004-08-01	Anderson et al.	Applicant
US6786382(B1)	2004-09-01	Hoffman	Applicant
US6786383(B2)	2004-09-01	Stegelmann	Applicant
US6790216(B1)	2004-09-01	Ishikawa	Applicant
USD496997(S)	2004-10-01	Dycus et al.	Applicant
US6802843(B2)	2004-10-01	Truckai et al.	Applicant
US6827712(B2)	2004-12-01	Tovey et al.	Applicant
US6828712(B2)	2004-12-01	Battaglin et al.	Applicant
US6869439(B2)	2005-03-01	White et al.	Applicant
US6875220(B2)	2005-04-01	Du et al.	Applicant
US6905497(B2)	2005-06-01	Truckai et al.	Applicant
US6908472(B2)	2005-06-01	Wiener et al.	Applicant
US6913579(B2)	2005-07-01	Truckai et al.	Applicant
US6923804(B2)	2005-08-01	Eggers et al.	Applicant
US6926716(B2)	2005-08-01	Baker et al.	Applicant
US6929632(B2)	2005-08-01	Nita et al.	Applicant
US6929644(B2)	2005-08-01	Truckai et al.	Applicant
US6933656(B2)	2005-08-01	Matsushita et al.	Applicant
USD509589(S)	2005-09-01	Wells	Applicant
US6942677(B2)	2005-09-01	Nita et al.	Applicant
US6945981(B2)	2005-09-01	Donofrio et al.	Applicant
USD511145(S)	2005-11-01	Donofrio et al.	Applicant
US6974450(B2)	2005-12-01	Weber et al.	Applicant
US6976844(B2)	2005-12-01	Hickok et al.	Applicant
US6976969(B2)	2005-12-01	Messerly	Applicant
US6977495(B2)	2005-12-01	Donofrio	Applicant
US6984220(B2)	2006-01-01	Wuchinich	Applicant
US7001335(B2)	2006-02-01	Adachi et al.	Applicant
US7011657(B2)	2006-03-01	Truckai et al.	Applicant
US7033357(B2)	2006-04-01	Baxter et al.	Applicant
US7041083(B2)	2006-05-01	Chu et al.	Applicant
US7041088(B2)	2006-05-01	Nawrocki et al.	Applicant
US7041102(B2)	2006-05-01	Truckai et al.	Applicant
US7070597(B2)	2006-07-01	Truckai et al.	Applicant
US7074219(B2)	2006-07-01	Levine et al.	Applicant
US7077039(B2)	2006-07-01	Gass et al.	Applicant
US7077853(B2)	2006-07-01	Kramer et al.	Applicant
US7083619(B2)	2006-08-01	Truckai et al.	Applicant
US7087054(B2)	2006-08-01	Truckai et al.	Applicant
US7090672(B2)	2006-08-01	Underwood et al.	Applicant
US7101371(B2)	2006-09-01	Dycus et al.	Applicant
US7101378(B2)	2006-09-01	Salameh et al.	Applicant
US7108695(B2)	2006-09-01	Witt et al.	Applicant
US7112201(B2)	2006-09-01	Truckai et al.	Applicant
USD531311(S)	2006-10-01	Guerra et al.	Applicant
US7118564(B2)	2006-10-01	Ritchie et al.	Applicant
US7124932(B2)	2006-10-01	Isaacson et al.	Applicant
US7125409(B2)	2006-10-01	Truckai et al.	Applicant
US7135018(B2)	2006-11-01	Ryan et al.	Applicant
US7135030(B2)	2006-11-01	Schwemberger et al.	Applicant
US7144403(B2)	2006-12-01	Booth	Applicant
US7153315(B2)	2006-12-01	Miller	Applicant
USD536093(S)	2007-01-01	Nakajima et al.	Applicant
US7156189(B1)	2007-01-01	Bar-Cohen et al.	Applicant
US7156853(B2)	2007-01-01	Muratsu	Applicant
US7157058(B2)	2007-01-01	Marhasin et al.	Applicant
US7159750(B2)	2007-01-01	Racenet et al.	Applicant
US7160299(B2)	2007-01-01	Baily	Applicant
US7163548(B2)	2007-01-01	Stulen et al.	Applicant
US7169146(B2)	2007-01-01	Truckai et al.	Applicant
US7179271(B2)	2007-02-01	Friedman et al.	Applicant
US7186253(B2)	2007-03-01	Truckai et al.	Applicant
US7189233(B2)	2007-03-01	Truckai et al.	Applicant
USD541418(S)	2007-04-01	Schechter et al.	Applicant
US7204820(B2)	2007-04-01	Akahoshi	Applicant
US7217269(B2)	2007-05-01	El-Galley et al.	Applicant
US7220951(B2)	2007-05-01	Truckai et al.	Applicant
US7223229(B2)	2007-05-01	Inman et al.	Applicant
US7229455(B2)	2007-06-01	Sakurai et al.	Applicant
US7273483(B2)	2007-09-01	Wiener et al.	Examiner
US7285895(B2)	2007-10-01	Beaupré	Applicant
US7309849(B2)	2007-12-01	Truckai et al.	Applicant
US7311709(B2)	2007-12-01	Truckai et al.	Applicant
US7317955(B2)	2008-01-01	McGreevy	Applicant
US7326236(B2)	2008-02-01	Andreas et al.	Applicant
US7331410(B2)	2008-02-01	Yong et al.	Applicant
US7353068(B2)	2008-04-01	Tanaka et al.	Applicant
US7354440(B2)	2008-04-01	Truckal et al.	Applicant
US7380695(B2)	2008-06-01	Doll et al.	Applicant
US7380696(B2)	2008-06-01	Shelton, IV et al.	Applicant
US7381209(B2)	2008-06-01	Truckai et al.	Applicant
US7390317(B2)	2008-06-01	Taylor et al.	Applicant
US7404508(B2)	2008-07-01	Smith et al.	Applicant
US7408288(B2)	2008-08-01	Hara	Applicant
USD576725(S)	2008-09-01	Shumer et al.	Applicant
USD578643(S)	2008-10-01	Shumer et al.	Applicant
USD578644(S)	2008-10-01	Shumer et al.	Applicant
USD578645(S)	2008-10-01	Shumer et al.	Applicant
US7431704(B2)	2008-10-01	Babaev	Applicant
US7441684(B2)	2008-10-01	Shelton, IV et al.	Applicant
US7455208(B2)	2008-11-01	Wales et al.	Applicant
US7472815(B2)	2009-01-01	Shelton, IV et al.	Applicant
US7473263(B2)	2009-01-01	Johnston et al.	Applicant
US7479148(B2)	2009-01-01	Beaupre	Applicant
US7479160(B2)	2009-01-01	Branch et al.	Applicant
US7488285(B2)	2009-02-01	Honda et al.	Applicant
US7494468(B2)	2009-02-01	Rabiner et al.	Applicant
US7503893(B2)	2009-03-01	Kucklick	Applicant
US7503895(B2)	2009-03-01	Rabiner et al.	Applicant
US7506790(B2)	2009-03-01	Shelton, IV	Applicant
US7506791(B2)	2009-03-01	Omaits et al.	Applicant
US7524320(B2)	2009-04-01	Tierney et al.	Applicant
US7530986(B2)	2009-05-01	Beaupre et al.	Applicant
US7534243(B1)	2009-05-01	Chin et al.	Applicant
USD594983(S)	2009-06-01	Price et al.	Applicant
US7549564(B2)	2009-06-01	Boudreaux	Applicant
US7559450(B2)	2009-07-01	Wales et al.	Applicant
US7567012(B2)	2009-07-01	Namikawa	Applicant
US7578820(B2)	2009-08-01	Moore et al.	Applicant
US7654431(B2)	2010-02-01	Hueil et al.	Applicant
US7665647(B2)	2010-02-01	Shelton, IV et al.	Applicant
US7670334(B2)	2010-03-01	Hueil et al.	Applicant
US7674263(B2)	2010-03-01	Ryan	Applicant
US7691098(B2)	2010-04-01	Wallace et al.	Applicant
US7713202(B2)	2010-05-01	Boukhny et al.	Examiner
US7714481(B2)	2010-05-01	Sakai	Applicant
USD618797(S)	2010-06-01	Price et al.	Applicant
US7751115(B2)	2010-07-01	Song	Applicant
USD621503(S)	2010-08-01	Otten et al.	Applicant
US7770774(B2)	2010-08-01	Mastri et al.	Applicant
US7770775(B2)	2010-08-01	Shelton, IV et al.	Applicant
US7780054(B2)	2010-08-01	Wales	Applicant
US7780659(B2)	2010-08-01	Okada et al.	Applicant
US7784662(B2)	2010-08-01	Wales et al.	Applicant
US7798386(B2)	2010-09-01	Schall et al.	Applicant
US7803152(B2)	2010-09-01	Honda et al.	Applicant
US7806891(B2)	2010-10-01	Nowlin et al.	Applicant
US7810693(B2)	2010-10-01	Broehl et al.	Applicant
USD627066(S)	2010-11-01	Romero	Applicant
US7824401(B2)	2010-11-01	Manzo et al.	Applicant
US7837699(B2)	2010-11-01	Yamada et al.	Applicant
US7846155(B2)	2010-12-01	Houser et al.	Applicant
US7854735(B2)	2010-12-01	Houser et al.	Applicant
USD631155(S)	2011-01-01	Peine et al.	Applicant
US7861906(B2)	2011-01-01	Doll et al.	Applicant
US7876030(B2)	2011-01-01	Taki et al.	Applicant
USD631965(S)	2011-02-01	Price et al.	Applicant
US7892606(B2)	2011-02-01	Thies et al.	Applicant
US7905881(B2)	2011-03-01	Masuda et al.	Applicant
US7922651(B2)	2011-04-01	Yamada et al.	Applicant
USD637288(S)	2011-05-01	Houghton	Applicant
USD638540(S)	2011-05-01	Ijiri et al.	Applicant
US7959050(B2)	2011-06-01	Smith et al.	Applicant
US7959626(B2)	2011-06-01	Hong et al.	Applicant
US7976544(B2)	2011-07-01	McClurken et al.	Applicant
US7998157(B2)	2011-08-01	Culp et al.	Applicant
US8038693(B2)	2011-10-01	Allen	Applicant
US8061014(B2)	2011-11-01	Smith et al.	Applicant
US8089197(B2)	2012-01-01	Rinner et al.	Applicant
US8152825(B2)	2012-04-01	Madan et al.	Applicant
US8157145(B2)	2012-04-01	Shelton, IV et al.	Applicant
US8177800(B2)	2012-05-01	Spitz et al.	Applicant
USD661801(S)	2012-06-01	Price et al.	Applicant
USD661802(S)	2012-06-01	Price et al.	Applicant
USD661803(S)	2012-06-01	Price et al.	Applicant
USD661804(S)	2012-06-01	Price et al.	Applicant
US8253303(B2)	2012-08-01	Giordano et al.	Applicant
US8287485(B2)	2012-10-01	Kimura et al.	Applicant
US2001/0025183(A1)	2001-09-01	Shahidi et al.	Applicant
US2001/0025184(A1)	2001-09-01	Messerly	Applicant
US2001/0031950(A1)	2001-10-01	Ryan	Applicant
US2001/0039419(A1)	2001-11-01	Francischelli et al.	Applicant
US2002/0002377(A1)	2002-01-01	Cimino	Applicant
US2002/0019649(A1)	2002-02-01	Sikora et al.	Applicant
US2002/0022836(A1)	2002-02-01	Goble et al.	Applicant
US2002/0049551(A1)	2002-04-01	Friedman et al.	Applicant
US2002/0052617(A1)	2002-05-01	Anis et al.	Applicant
US2002/0077550(A1)	2002-06-01	Rabiner et al.	Applicant
US2002/0156466(A1)	2002-10-01	Sakurai et al.	Applicant
US2002/0156493(A1)	2002-10-01	Houser et al.	Applicant
US2003/0036705(A1)	2003-02-01	Hare et al.	Applicant
US2003/0055443(A1)	2003-03-01	Spotnitz	Applicant
US2003/0204199(A1)	2003-10-01	Novak et al.	Applicant
US2003/0212332(A1)	2003-11-01	Fenton et al.	Applicant
US2003/0212422(A1)	2003-11-01	Fenton et al.	Applicant
US2003/0229344(A1)	2003-12-01	Dycus et al.	Applicant
US2004/0030254(A1)	2004-02-01	Babaev	Applicant
US2004/0047485(A1)	2004-03-01	Sherrit et al.	Applicant
US2004/0054364(A1)	2004-03-01	Aranyi et al.	Applicant
US2004/0092921(A1)	2004-05-01	Kadziauskas et al.	Applicant
US2004/0097919(A1)	2004-05-01	Wellman et al.	Applicant
US2004/0097996(A1)	2004-05-01	Rabiner et al.	Applicant
US2004/0176686(A1)	2004-09-01	Hare et al.	Applicant
US2004/0199193(A1)	2004-10-01	Hayashi et al.	Applicant
US2004/0204728(A1)	2004-10-01	Haefner	Applicant
US2004/0243157(A1)	2004-12-01	Connor et al.	Applicant
US2004/0260300(A1)	2004-12-01	Gorensek et al.	Applicant
US2005/0004589(A1)	2005-01-01	Okada et al.	Examiner
US2005/0021065(A1)	2005-01-01	Yamada et al.	Applicant
US2005/0033337(A1)	2005-02-01	Muir et al.	Applicant
US2005/0049546(A1)	2005-03-01	Messerly et al.	Applicant
US2005/0070800(A1)	2005-03-01	Takahashi	Applicant
US2005/0096683(A1)	2005-05-01	Ellins et al.	Applicant
US2005/0143769(A1)	2005-06-01	White et al.	Applicant
US2005/0149108(A1)	2005-07-01	Cox	Applicant
US2005/0165345(A1)	2005-07-01	Laufer et al.	Applicant
US2005/0177184(A1)	2005-08-01	Easley	Applicant
US2005/0192610(A1)	2005-09-01	Houser et al.	Applicant
US2005/0209620(A1)	2005-09-01	Du et al.	Applicant
US2005/0261581(A1)	2005-11-01	Hughes et al.	Applicant
US2005/0261588(A1)	2005-11-01	Makin et al.	Applicant
US2005/0273090(A1)	2005-12-01	Nieman et al.	Applicant
US2005/0288659(A1)	2005-12-01	Kimura et al.	Applicant
US2006/0030797(A1)	2006-02-01	Zhou et al.	Applicant
US2006/0063130(A1)	2006-03-01	Hayman et al.	Applicant
US2006/0066181(A1)	2006-03-01	Bromfield et al.	Applicant
US2006/0079876(A1)	2006-04-01	Houser et al.	Applicant
US2006/0079878(A1)	2006-04-01	Houser	Applicant
US2006/0084963(A1)	2006-04-01	Messerly	Applicant
US2006/0095046(A1)	2006-05-01	Trieu et al.	Applicant
US2006/0190034(A1)	2006-08-01	Nishizawa et al.	Applicant
US2006/0206115(A1)	2006-09-01	Schomer et al.	Applicant
US2006/0211943(A1)	2006-09-01	Beaupre	Applicant
US2006/0235306(A1)	2006-10-01	Cotter et al.	Applicant
US2006/0253050(A1)	2006-11-01	Yoshimine et al.	Applicant
US2006/0264809(A1)	2006-11-01	Hansmann et al.	Applicant
US2007/0016235(A1)	2007-01-01	Tanaka et al.	Applicant
US2007/0016236(A1)	2007-01-01	Beaupre	Applicant
US2007/0055228(A1)	2007-03-01	Berg et al.	Applicant
US2007/0056596(A1)	2007-03-01	Fanney et al.	Applicant
US2007/0060915(A1)	2007-03-01	Kucklick	Applicant
US2007/0060935(A1)	2007-03-01	Schwardt et al.	Applicant
US2007/0063618(A1)	2007-03-01	Bromfield	Applicant
US2007/0106317(A1)	2007-05-01	Shelton, IV et al.	Applicant
US2007/0129716(A1)	2007-06-01	Daw et al.	Applicant
US2007/0130771(A1)	2007-06-01	Ehlert et al.	Applicant
US2007/0131034(A1)	2007-06-01	Ehlert et al.	Applicant
US2007/0149881(A1)	2007-06-01	Rabin	Applicant
US2007/0162050(A1)	2007-07-01	Sartor	Applicant
US2007/0173872(A1)	2007-07-01	Neuenfeldt	Applicant
US2007/0185380(A1)	2007-08-01	Kucklick	Applicant
US2007/0219481(A1)	2007-09-01	Babaev	Applicant
US2007/0239028(A1)	2007-10-01	Houser et al.	Applicant
US2007/0249941(A1)	2007-10-01	Salehi et al.	Applicant
US2007/0260234(A1)	2007-11-01	McCullagh et al.	Applicant
US2007/0265560(A1)	2007-11-01	Soltani et al.	Applicant
US2007/0275348(A1)	2007-11-01	Lemon	Applicant
US2007/0282335(A1)	2007-12-01	Young et al.	Applicant
US2007/0287933(A1)	2007-12-01	Phan et al.	Applicant
US2008/0009848(A1)	2008-01-01	Paraschiv et al.	Applicant
US2008/0051812(A1)	2008-02-01	Schmitz et al.	Applicant
US2008/0058585(A1)	2008-03-01	Novak et al.	Applicant
US2008/0058775(A1)	2008-03-01	Darian et al.	Applicant
US2008/0058845(A1)	2008-03-01	Shimizu et al.	Applicant
US2008/0082039(A1)	2008-04-01	Babaev	Applicant
US2008/0082098(A1)	2008-04-01	Tanaka et al.	Applicant
US2008/0125768(A1)	2008-05-01	Tahara et al.	Applicant
US2008/0171938(A1)	2008-07-01	Masuda et al.	Applicant
US2008/0172051(A1)	2008-07-01	Masuda et al.	Examiner
US2008/0177268(A1)	2008-07-01	Daum et al.	Applicant
US2008/0188878(A1)	2008-08-01	Young	Applicant
US2008/0200940(A1)	2008-08-01	Eichmann et al.	Applicant
US2008/0208231(A1)	2008-08-01	Ota et al.	Applicant
US2008/0234708(A1)	2008-09-01	Houser et al.	Applicant
US2008/0234709(A1)	2008-09-01	Houser	Applicant
US2008/0234710(A1)	2008-09-01	Neurohr et al.	Applicant
US2008/0234711(A1)	2008-09-01	Houser et al.	Applicant
US2008/0243106(A1)	2008-10-01	Coe et al.	Applicant
US2008/0245371(A1)	2008-10-01	Gruber	Applicant
US2008/0249553(A1)	2008-10-01	Gruber et al.	Applicant
US2008/0262490(A1)	2008-10-01	Williams	Applicant
US2008/0281200(A1)	2008-11-01	Voic et al.	Applicant
US2008/0287948(A1)	2008-11-01	Newton et al.	Applicant
US2009/0030311(A1)	2009-01-01	Stulen et al.	Applicant
US2009/0030351(A1)	2009-01-01	Wiener et al.	Applicant
US2009/0030437(A1)	2009-01-01	Houser et al.	Applicant
US2009/0030438(A1)	2009-01-01	Stulen	Applicant
US2009/0030439(A1)	2009-01-01	Stulen	Applicant
US2009/0036911(A1)	2009-02-01	Stulen	Applicant
US2009/0036912(A1)	2009-02-01	Wiener et al.	Applicant
US2009/0036913(A1)	2009-02-01	Wiener et al.	Applicant
US2009/0036914(A1)	2009-02-01	Houser	Applicant
US2009/0048537(A1)	2009-02-01	Lydon et al.	Applicant
US2009/0054886(A1)	2009-02-01	Yachi et al.	Applicant
US2009/0054894(A1)	2009-02-01	Yachi	Applicant
US2009/0076506(A1)	2009-03-01	Baker	Applicant
US2009/0082716(A1)	2009-03-01	Akahoshi	Applicant
US2009/0105750(A1)	2009-04-01	Price et al.	Applicant
US2009/0118802(A1)	2009-05-01	Mioduski et al.	Applicant
US2009/0138006(A1)	2009-05-01	Bales et al.	Applicant
US2009/0143795(A1)	2009-06-01	Robertson	Applicant
US2009/0143796(A1)	2009-06-01	Stulen et al.	Applicant
US2009/0143797(A1)	2009-06-01	Smith et al.	Applicant
US2009/0143798(A1)	2009-06-01	Smith et al.	Applicant
US2009/0143799(A1)	2009-06-01	Smith et al.	Applicant
US2009/0143800(A1)	2009-06-01	Deville et al.	Applicant
US2009/0143801(A1)	2009-06-01	Deville et al.	Applicant
US2009/0143802(A1)	2009-06-01	Deville et al.	Applicant
US2009/0143803(A1)	2009-06-01	Palmer et al.	Applicant
US2009/0143804(A1)	2009-06-01	Palmer et al.	Applicant
US2009/0143805(A1)	2009-06-01	Palmer et al.	Applicant
US2009/0143806(A1)	2009-06-01	Witt et al.	Applicant
US2009/0149801(A1)	2009-06-01	Crandall et al.	Applicant
US2009/0270853(A1)	2009-10-01	Yachi et al.	Applicant
US2009/0270899(A1)	2009-10-01	Carusillo et al.	Applicant
US2009/0318945(A1)	2009-12-01	Yoshimine et al.	Applicant
US2009/0327715(A1)	2009-12-01	Smith et al.	Applicant
US2010/0004668(A1)	2010-01-01	Smith et al.	Applicant
US2010/0004669(A1)	2010-01-01	Smith et al.	Applicant
US2010/0016785(A1)	2010-01-01	Takuma	Applicant
US2010/0030248(A1)	2010-02-01	Palmer et al.	Applicant
US2010/0036370(A1)	2010-02-01	Mirel et al.	Applicant
US2010/0036405(A1)	2010-02-01	Giordano et al.	Applicant
US2010/0069940(A1)	2010-03-01	Miller et al.	Applicant
US2010/0158307(A1)	2010-06-01	Kubota et al.	Applicant
US2010/0179577(A1)	2010-07-01	Houser	Applicant
US2010/0187283(A1)	2010-07-01	Crainich et al.	Applicant
US2010/0193567(A1)	2010-08-01	Scheib et al.	Applicant
US2010/0228264(A1)	2010-09-01	Robinson et al.	Applicant
US2010/0234906(A1)	2010-09-01	Koh	Applicant
US2010/0268211(A1)	2010-10-01	Manwaring et al.	Applicant
US2010/0298743(A1)	2010-11-01	Nield et al.	Applicant
US2010/0298851(A1)	2010-11-01	Nield	Applicant
US2010/0331869(A1)	2010-12-01	Voegele et al.	Applicant
US2010/0331870(A1)	2010-12-01	Wan et al.	Applicant
US2010/0331871(A1)	2010-12-01	Nield et al.	Applicant
US2010/0331872(A1)	2010-12-01	Houser et al.	Applicant
US2011/0009850(A1)	2011-01-01	Main et al.	Applicant
US2011/0015631(A1)	2011-01-01	Wiener et al.	Applicant
US2011/0015660(A1)	2011-01-01	Wiener et al.	Applicant
US2011/0082486(A1)	2011-04-01	Messerly et al.	Applicant
US2011/0087212(A1)	2011-04-01	Aldridge et al.	Applicant
US2011/0087213(A1)	2011-04-01	Messerly et al.	Applicant
US2011/0087214(A1)	2011-04-01	Giordano et al.	Applicant
US2011/0087215(A1)	2011-04-01	Aldridge et al.	Applicant
US2011/0087216(A1)	2011-04-01	Aldridge et al.	Applicant
US2011/0087217(A1)	2011-04-01	Yates et al.	Applicant
US2011/0087218(A1)	2011-04-01	Boudreaux et al.	Applicant
US2011/0087256(A1)	2011-04-01	Wiener et al.	Applicant
US2011/0125175(A1)	2011-05-01	Stulen et al.	Applicant
US2011/0196286(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196287(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196398(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196399(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196400(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196401(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196402(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196403(A1)	2011-08-01	Robertson et al.	Applicant
US2011/0196404(A1)	2011-08-01	Dietz et al.	Applicant
US2011/0196405(A1)	2011-08-01	Dietz	Applicant
US2011/0288452(A1)	2011-11-01	Houser et al.	Applicant
US2012/0029546(A1)	2012-02-01	Robertson	Applicant
US2012/0059289(A1)	2012-03-01	Nield et al.	Applicant
US2012/0078139(A1)	2012-03-01	Aldridge et al.	Applicant
US2012/0078243(A1)	2012-03-01	Worrell et al.	Applicant
US2012/0078244(A1)	2012-03-01	Worrell et al.	Applicant
US2012/0078247(A1)	2012-03-01	Worrell et al.	Applicant
US2012/0083783(A1)	2012-04-01	Davison et al.	Applicant
US2012/0083784(A1)	2012-04-01	Davison et al.	Applicant
US2012/0132450(A1)	2012-05-01	Timm et al.	Applicant
US2012/0138660(A1)	2012-06-01	Shelton, IV	Applicant
US2012/0177005(A1)	2012-07-01	Liang et al.	Applicant
US2012/0184946(A1)	2012-07-01	Price et al.	Applicant
US2012/0199630(A1)	2012-08-01	Shelton, IV	Applicant
US2012/0199631(A1)	2012-08-01	Shelton, IV et al.	Applicant
US2012/0199632(A1)	2012-08-01	Spivey et al.	Applicant
US2012/0199633(A1)	2012-08-01	Shelton, IV et al.	Applicant
US2012/0203247(A1)	2012-08-01	Shelton, IV et al.	Applicant
US2012/0203257(A1)	2012-08-01	Stulen et al.	Applicant
US2012/0205421(A1)	2012-08-01	Shelton, IV	Applicant
US2012/0210223(A1)	2012-08-01	Eppolito	Applicant
US2012/0211546(A1)	2012-08-01	Shelton, IV	Applicant
US2012/0259353(A1)	2012-10-01	Houser et al.	Applicant
US2012/0265196(A1)	2012-10-01	Turner et al.	Applicant
US2012/0269676(A1)	2012-10-01	Houser et al.	Applicant
US2012/0289984(A1)	2012-11-01	Houser et al.	Applicant
US2012/0310262(A1)	2012-12-01	Messerly et al.	Applicant
US2012/0310263(A1)	2012-12-01	Messerly et al.	Applicant
US2012/0310264(A1)	2012-12-01	Messerly et al.	Applicant
US2012/0323265(A1)	2012-12-01	Stulen	Applicant
US2013/0012970(A1)	2013-01-01	Houser	Applicant
US2013/0103023(A1)	2013-04-01	Monson et al.	Applicant
US2013/0103024(A1)	2013-04-01	Monson et al.	Applicant
US2013/0123776(A1)	2013-05-01	Monson et al.	Applicant
US2013/0123777(A1)	2013-05-01	Monson et al.	Applicant
US2013/0123782(A1)	2013-05-01	Trees et al.	Applicant
CN1634601(A)	2005-07-01		Applicant
CN1640365(A)	2005-07-01		Applicant
CN1694649(A)	2005-11-01		Applicant
CN1922563(A)	2007-02-01		Applicant
CN1951333(A)	2007-04-01		Applicant
CN101040799(A)	2007-09-01		Applicant
CN101467917(A)	2009-01-01		Applicant
EP171967(A2)	1986-02-01		Applicant
EP443256(A1)	1991-08-01		Applicant
EP456470(A1)	1991-11-01		Applicant
EP482195(B1)	1992-04-01		Applicant
EP482195(B1)	1996-01-01		Applicant
EP612570(B1)	1997-06-01		Applicant
EP908148(B1)	2002-01-01		Applicant
EP908155(B1)	2003-06-01		Applicant
EP1199044(B1)	2005-12-01		Applicant
EP1199043(B1)	2006-03-01		Applicant
EP1433425(B1)	2006-06-01		Applicant
EP1844720(A1)	2007-10-01		Applicant
EP1862133(A1)	2007-12-01		Applicant
EP1199045(B1)	2008-06-01		Applicant
EP1974771(A1)	2008-10-01		Applicant
EP1498082(B1)	2008-12-01		Applicant
EP1832259(B1)	2009-06-01		Applicant
EP2074959(A1)	2009-07-01		Applicant
EP2298154(A2)	2011-03-01		Applicant
GB2032221(A)	1980-04-01		Applicant
GB2379878(B)	2004-11-01		Applicant
GB2447767(B)	2011-08-01		Applicant
JP62-292153(A)	1987-12-01		Applicant
JP63-315049(A)	1988-12-01		Applicant
JP2-71510(U)	1990-05-01		Applicant
JP4-25707(U)	1992-02-01		Applicant
JP4-30508(U)	1992-03-01		Applicant
JP6-104503(A)	1994-04-01		Applicant
JP6-705081(A)	1994-08-01		Applicant
JPH7-508910(A)	1995-10-01		Applicant
JP7-308323(A)	1995-11-01		Applicant
JP8-24266(A)	1996-01-01		Applicant
JP8-275951(A)	1996-10-01		Applicant
JPH09-503146(A)	1997-03-01		Applicant
JP10-295700(A)	1998-11-01		Applicant
JP11-253451(A)	1999-09-01		Applicant
JP2000-041991(A)	2000-02-01		Applicant
JP2000-070279(A)	2000-03-01		Applicant
JP2001-309925(A)	2001-11-01		Applicant
JP2002-186901(A)	2002-07-01		Applicant
JP2002-263579(A)	2002-09-01		Applicant
JP2003-510158(A)	2003-03-01		Applicant
JP2003-126110(A)	2003-05-01		Applicant
JP2003-310627(A)	2003-05-01		Applicant
JP2003-339730(A)	2003-12-01		Applicant
JP2005027026(A)	2005-01-01		Applicant
JP2005-066316(A)	2005-03-01		Applicant
JP2005-074088(A)	2005-03-01		Applicant
JP2005-534451(A)	2005-11-01		Applicant
JP2006-158525(A)	2006-06-01		Applicant
JP2006217716(A)	2006-08-01		Applicant
JP2007-050181(A)	2007-03-01		Applicant
JP2007-229454(A)	2007-09-01		Applicant
JP2008-508065(A)	2008-03-01		Applicant
JP2008-119250(A)	2008-05-01		Applicant
JP2009-511206(A)	2009-03-01		Applicant
JP2009-523567(A)	2009-06-01		Applicant
WO92/22259(A2)	1992-12-01		Applicant
WO93/14708(A1)	1993-08-01		Applicant
WO94/21183(A1)	1994-09-01		Applicant
WO95/09572(A1)	1995-04-01		Applicant
WO98/26739(A1)	1998-06-01		Applicant
WO98/37815(A1)	1998-09-01		Applicant
WO1/54590(A1)	2001-08-01		Applicant
WO1/95810(A2)	2001-12-01		Applicant
WO2004/037095(A2)	2004-05-01		Applicant
WO2005/122917(A1)	2005-12-01		Applicant
WO2006/012797(A1)	2006-02-01		Applicant
WO2006/042210(A2)	2006-04-01		Applicant
WO2006/058223(A2)	2006-06-01		Applicant
WO2006/063199(A2)	2006-06-01		Applicant
WO2006/083988(A1)	2006-08-01		Applicant
WO2006/129465(A1)	2006-12-01		Applicant
WO2007/008710(A2)	2007-01-01		Applicant
WO2007/047531(A2)	2007-04-01		Applicant
WO2007/087272(A2)	2007-08-01		Applicant
WO2007/143665(A2)	2007-12-01		Applicant
WO2008/016886(A2)	2008-02-01		Applicant
WO2008/042021(A1)	2008-04-01		Applicant
WO2008/130793(A1)	2008-10-01		Applicant
WO2009/018406(A2)	2009-02-01		Applicant
WO2009/027065(A1)	2009-03-01		Applicant
WO2011/144911(A1)	2011-11-01		Applicant

Non-Patent Literature (70)

Partial International Search Report for PCT/US2010/041663, Oct. 28, 2010 (2 pages).Applicant
U.S. Appl. No. 12/703,860, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,864, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,866, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,870, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,875, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,877, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,879, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,885, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,893, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 12/703,899, filed Feb. 11, 2010.Applicant
U.S. Appl. No. 29/361,917, filed May 17, 2010.Applicant
U.S. Appl. No. 12/896,351, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,479, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,360, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,345, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,384, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,467, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,451, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,470, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,411, filed Oct. 1, 2010.Applicant
U.S. Appl. No. 12/896,420, filed Oct. 1, 2010.Applicant
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973).Applicant
Incropera et al., Fundamentals of Heat and Mass Transfer, Wiley, New York (1990). (Book—not attached).Applicant
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990).Applicant
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van GeMert, eds., Plenum, New York (1995).Applicant
Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008).Applicant
U.S. Appl. No. 29/402,697, filed Sep. 26, 2011.Applicant
U.S. Appl. No. 29/402,699, filed Sep. 26, 2011.Applicant
U.S. Appl. No. 29/402,700, filed Sep. 26, 2011.Applicant
U.S. Appl. No. 29/402,701, filed Sep. 26, 2011.Applicant
U.S. Appl. No. 13/251,766, filed Oct. 3, 2011.Applicant
U.S. Appl. No. 29/404,676, filed Oct. 24, 2011.Applicant
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages).Applicant
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002.Applicant
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006).Applicant
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003).Applicant
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages).Applicant
U.S. Appl. No. 29/327,737, filed Nov. 12, 2008.Applicant
U.S. Appl. No. 12/469,293, filed May 20, 2009.Applicant
U.S. Appl. No. 12/469,308, filed May 20, 2009.Applicant
U.S. Appl. No. 12/490,906, filed Jun. 24, 2009.Applicant
U.S. Appl. No. 12/490,922, filed Jun. 24, 2009.Applicant
U.S. Appl. No. 12/490,933, filed Jun. 24, 2009.Applicant
U.S. Appl. No. 12/490,948, filed Jun. 24, 2009.Applicant
U.S. Appl. No. 12/503,775, filed Jul. 15, 2009.Applicant
U.S. Appl. No. 12/503,769, filed Jul. 15, 2009.Applicant
U.S. Appl. No. 12/503,770, filed Jul. 15, 2009.Applicant
International Preliminary Report on Patentability for PCT/US2010/041663, Jan. 17, 2012 (8 pages).Applicant
U.S. Appl. No. 13/294,576, filed Nov. 11, 2011.Applicant
International Search Report for PCT/US2010/041663, Feb. 17, 2011 (8 pages).Applicant
U.S. Appl. No. 13/448,175, filed Apr. 16, 2012.Applicant
U.S. Appl. No. 13/151,181, filed Jun. 2, 2011.Applicant
U.S. Appl. No. 13/369,561, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,569, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,578, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,584, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,588, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,594, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,601, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,609, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,629, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/369,666, filed Feb. 9, 2012.Applicant
U.S. Appl. No. 13/545,292, filed Jul. 10, 2012.Applicant
U.S. Appl. No. 13/584,020, filed Aug. 13, 2012.Applicant
U.S. Appl. No. 13/584,445, filed Aug. 13, 2012.Applicant
U.S. Appl. No. 13/584,878, filed Aug. 14, 2012.Applicant
U.S. Appl. No. 13/585,124, filed Aug. 14, 2012.Applicant
U.S. Appl. No. 13/585,292, filed Aug. 14, 2012.Applicant
U.S. Appl. No. 13/849,627, filed Mar. 25, 2013.Applicant